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Olfactory ensheathing cells from the adult olfactory bulb (OECs) have 
been shown at our laboratory to facilitate axon regeneration in the 
spinal cord. They share similarities with Schwann cells at the 
histological level but appear to be more efficient at promoting axon 
regeneration. In particular, they enable axons to leave the transplant 
and re-enter the host CNS and establish lost connections with the 
target area. OECs and Schwann cells have been used at different 
stages of maturity and at varying purities. Besides these two cell 
types there are other candidate repair cells, most notably neural stem 
cells and OECs from the olfactory mucosa which may also be of use 
in reconstruction of severed fibre tracts. For screening the reparative 
abilities of these different cell types experiments in the spinal cord 
are time-consuming and technically challenging. The following 
experiments were therefore designed to address the need for an 
assay system to allow comparison of various candidate repair cells 
and deliver reliable, time-efficient and reproducible results.
Based on previous work from this laboratory, stereotaxically guided 
microinjection of cell suspensions into the lateral ventroposterior 
thalamic nucleus (VPL) was used to compare the behaviour of 
different cell types in terms of cell survival, cell migration, interaction 
with the host tissue and axon recruitment. OECs, adult Schwann 
cells (ASCs), neonatal Schwann cells (NSCs), neural crest stem cells
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(NCSSs) and OECs derived from either the rat or human olfactory 
mucosa were investigated. The sham group only received injections 
of medium into the thalamus.
Approximately 3-5 \i\ of cell suspension at a concentration of 100x106 
cells/ml was injected into the thalamus via a micropipette that was 
slowly withdrawn so as to lay an artificial tract of the grafted cells. 
Animals were culled after survival times of one, two and three weeks 
and their brains processed for immunohistochemistry. Donor cells 
were identified by expression of the low affinity nerve growth factor 
receptor (p75), fibronectin and nestin. OECs from surgical biopsy 
samples of the human olfactory mucosa were detected by an 
antibody directed against human mitochondria (MIT) or by a human- 
specific p75 antibody. Axons were identified by immunoreactivity for 
neurofilament (NF). Host astrocytes and their processes were 
identified by glial fibrillary acidic protein (GFAP). An antibody against 
peripherin was used to identify NCSSs.
Samples were processed for immunohistochemistry based on the 
avidin-biotin complex method or for immunofluorescence studies 
using confocal microscopy. Immunohistochemistry was primarily 
employed to obtain tissue slides for quantitative assessment and to 
examine the immune response to human OECs transplanted into the 
thalamus.
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Histological sections were then subjected to both qualitative and 
quantitative analysis. For qualitative analysis cell alignment and 
survival, interactions between host and donor tissue, and the 
recruitment of axons were examined.
The qualitative analysis showed all cell types survived. The cells 
formed a vertically orientated column aligned in parallel strands along 
the line of the pipette penetration of the thalamus. Differences in the 
shape and alignment of cells were noted. Neonatal Schwann cells 
and OECs from the rat mucosa displayed the highest degree of 
alignment and cells had long and slender cell nuclei in contrast to 
OECs from the bulb that had nuclei of plump and more oval 
morphology. NSC, ASC and OECs from bulb and mucosa could all 
be identified by p75. Fibronectin staining identified fibroblasts in 
OECs and Schwann cell transplants. Columns derived from all cell 
types were capable of recruiting axons. The astrocytic processes 
appeared to provide a guidance structure for axons. Astrocytes in 
close vicinity of the graft were hypertrophied but no significant 
differences were observed in their response to the different 
transplanted cell types employed.
NCSSs behaved in much the same way in vivo as they did in vitro. 
They differentiated into either neurons of immunohistochemically 
peripheral type or Schwann cell-like glial cells. They also appeared
to recruit axons but it was impossible to ascertain the origin or 
destination of delicate axons seen inside the graft.
Human xenografts were investigated for immune rejection using 
antibodies directed against CD4, CD8, MHC I and MHC II. OECs 
derived from the human olfactory mucosa were invariably rejected by 
the rat immune system if only oral immunosuppression with 
cyclosporine was employed. The immune response was significantly 
reduced in animals receiving systemic cyclosporine with few 
lymphocytes infiltrating the graft and better cell survival. However, 
the immune response was not completely abolished. The grafts 
were surrounded by MHC ll-positive cells of microglial origin, but 
some grafted OECs could clearly be identified and survived well. 
The immune response measured by the degree of perivascular 
lymphocyte cuffing was notably stronger in animals that had only 
received oral cyclosporine. Perivascular cuffing of lymphocytes, a 
hallmark or intense rejection, was clearly visible in the vicinity of 
human grafts in orally treated animals. These cells also often 
displayed a honey-comb like arrangement and focal areas of 
necrosis.
Quantitative analysis was carried out for all cell types except NCSSs. 
It revealed that all cell types could recruit axons at a higher density 
than the sham group. NSC recruited the longest axons and at the 
highest density. There were unexpected differences between OECs
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obtained from the rat olfactory bulb and those from the olfactory 
mucosa, with the latter cell type being almost as successful at axon 
recruitment as the NSC in terms of mean axon density and mean 
axon length. OECs from the bulb recruited axons at far lesser 
density and axons of slightly shorter length than their counterparts 
from the olfactory mucosa. Axon density and mean axon length for 
adult Schwann cells fell between that for OECs from the bulb and 
NSCs. OECs from the human olfactory mucosa attracted the least 
number of axons which did not differ much from the sham group, 
although they achieved a slightly higher axon density than the sham 
group after 2 weeks. The mean axon length was comparable to the 
sham group. These measurements probably reflect persistent 
immunorejection of the graft despite the fact that these animals had 
received systemic immunosuppression with cyclosporine.
The thalamus as a model did not lend itself to the study of axon re­
entry into the host parenchyma given the lack of a suitable labelling 
method and a well-defined pathway. Hence, the postcommissural 
fornix was chosen to investigate host re-entry of fibres. The fornix is 
a very accessible white matter tract with a well-defined unilateral 
projection to the mammillary body. Radiofrequency heat lesions 
were generated with an electrode that was stereotaxically lowered to 
a point crossing the path of the post commissural fornix. Following 
removal of the electrode, a micropipette was then lowered to the 
lesion site and the cell suspension injected. In the final step the
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fornix was labelled by injecting the subiculum with 2 jj,I of a 10 % 
solution of the tracer biotin dextran. For the main experiments, biotin 
dextran (BD)-labelling was performed shortly after the lesion had 
been generated, and the cell suspension had been injected. In some 
experiments, animals were labelled at the time of delayed grafting.
OECs and NSCs were transplanted into the fornix. The cells were 
identified with p75. Typically, a small column had formed at the 
dorsal site of the lesion, which ended in a somewhat spherical bolus 
of cells filling the lesion cavity. The bolus often had a central, 
necrotic core. In all cases, fornix fibres failed to advance into or past 
the lesion site. Regeneration into the bolus also failed when cells 
were transplanted with a 2 weeks delay. BD-labelled axons in close 
proximity to the lesion became thickened, exhibited many varicosities 
and often ended in growth-cone-like expansions. These axons 
resembled axons in pure lesions without grafting of cell suspensions, 
and just like them sprouted at the point were they came into contact 
with the lesion site.
Although axons were unable to advance into the lesion site, cells 
were seen to migrate from the graft into the proximal and distal ends 
of the severed fornix. At the proximal end cells clearly intermingled 
with the BD-labelled fibres. Interestingly, NF-immunoreactive axons 
were seen in both column and bolus but their origin could not be 
determined.
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Embryonic rat brain cells obtained from whole brain preparations of 
14 day old embryos failed to enable regeneration past the lesion site 
just like in the other cell types. These cells had a heterogeneous 
distribution and differentiated into various cell types. They 
sometimes appeared to be organised in subpopulations. They did 
neither express p75 nor GFAP with the exception of cells adjacent to 





Damage to the central nervous system (CNS) as in stroke, head and 
spinal cord injury has devastating effects on the affected individual. 
The main problem exemplified by spinal cord injury is the disruption 
or severance of white matter tracts. After disruption, these fibre 
tracts fail to regenerate spontaneously. Severed nerve fibres in the 
adult CNS sprout in response to injury but do not elongate along their 
original pathways. Injury to the adult CNS is essentially an 
irreversible event. In the peripheral nervous system (PNS), the 
developing CNS, fish and amphibians the situation is quite different 
and cut fibres there are able to re-establish their original pathways 
and form synaptic connections with their former targets. This 
observation gave rise to the idea that the properties of a more 
permissive environment for regeneration, like the PNS, could be 
transferred to the adult CNS. Unlike the CNS, fibres in the PNS are 
able to regrow to their original destination and restore function. The 
striking differences between the PNS and CNS environments are 
highlighted by injury to the dorsal root fibres. Following axotomy, 
fibres are able to grow back along their original pathway outside the 
CNS but once they reach the CNS/PNS interface they fail to advance 
into the CNS.
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Regeneration of cut axons requires several steps in succession. 
Firstly, severed fibres have to advance into the tissue bridge or cell 
transplant at the lesion site. They then have to extend through the 
graft and eventually leave the graft to re-enter the host CNS. In the 
last step, the axons have to trace their original way back to the target 
area and establish new synaptic connections. Functional 
regeneration will also require remyelination of the reconnected fibres.
Schwann cells
In 1928 Ramon y Cajal published the experiments of his pupil Tello 
who in 1911 was the first to attempt the transplantation of a 
conditioned sciatic nerve into the adult CNS (Cajal, 1928). It took 70 
years before this idea was re-explored and the experiment replicated 
by Aguayo and co-workers (Richardson et al., 1980). Aguayo 
investigated the regenerative abilities of a sciatic nerve grafted into 
the spinal cord extensively. Horseradish peroxidase (HRP) and 
radioautographic axonal tracing in the thoracic spinal cord revealed 
that axons were innervating the graft but had failed to re-enter the 
rostral spinal cord stumps (Richardson et al., 1982). Some axons in 
the grafts originated from intrinsic CNS neurons with their cell bodies 
in nearby segments of the spinal cord, whereas others arose from 
the dorsal root ganglia. However, the corticospinal tract did not 
contribute any fibres.
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In an extension of these earlier experiments, Schwann cells were 
cultured from peripheral nerve and transplanted as cell suspensions 
into the CNS. This enabled a less traumatic transplantation 
procedure and a more accurate cell placement. Such grafts 
transplanted into the spinal cord are able to attract fibres into the 
graft, but once again the axons are unable to leave the transplant 
and make contact with the CNS (Li and Raisman, 1995). Even 
genetically engineered Schwann cells, designed to secrete brain- 
drived neurotrophic factor (BDNF), were unable to mediate re-entry 
of fibres into the spinal cord (Menei et al., 1998). Newer studies 
however, seem to indicate that limited host re-entry is possible under 
special circumstances (Xu et al., 1999). While Schwann cells seem 
to have a limited potential for regeneration in the spinal cord, some 
as yet unconfirmed reports claim that they guide back axons to their 
original destination at other sites of the CNS (post-commissural 
fornix; Stichel et al., 1996, and the septo-hippocampal cholinergic 
pathway; Montero-Menei etal., 1992).
Neural stem cells
Neural stem cells are traditionally defined by their ability either to 
renew themselves thereby replenishing a pool of stem cells 
(symmetrical division) or to differentiate into mature cell types 
(asymmetrical division). Neural stem cells are defined as having the 
potential to generate all the major cell types found in the CNS but it is
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thought that once the cells have differentiated into progenitors of 
either neuronal or glial lineage they are restricted to a specific cell 
fate and cannot revert to an earlier state.
In modification of this original concept of stem cells there is 
increasingly evidence to support a more dynamic concept (Blau et 
al., 2001) of stem cells. Cell that would be considered as progenitor 
cells (immature cells that have a more lineage-restricted 
differentiation potential than stem cells) have the ability to self- 
replicate and cells that have apparently reached maturity (Dupin et 
al., 2003) might de-differentiate again under certain circumstances 
and even trans-differentiate to a different lineage (Koshizuka et al., 
2004). Nevertheless, it is useful at least for working purposes to 
consider stem cells as cells capable of both self-renewal and 
differentiation into lineage-restricted progenitors that give eventually 
give rise to specific mature CNS cells of different classes.
Phenotypically, both stem cells and progenitor cells stain for the 
marker nestin (Dahlstrand et al., 1995). There are a growing number 
of other stem cell markers like Presenilin, Notch, and Numb but none 
of them appear to be uniquely specific for stem cells (Maslov et al., 
2004;Cai et al., 2002;Cai et al., 2003).
Proof for a given cell being a neural stem cell is normally obtained 
from functional in-vitro assays. Neural stem cells can be expanded
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as clones if they are cultured as neurospheres (Reynolds and Weiss, 
1992) in serum-free medium. Single cells obtained from 
neurospheres can form new neurospheres or they can be 
differentiated into glia and neurones.
Various parts of the postnatal and adult CNS contain cells capable of 
forming new cells. Most notably are the dentate gyrus of the 
hippocampus, the subventricular zone (SVZ) (Levison et al., 2003) 
and the olfactory bulb (Liu and Martin, 2003) as well as the olfactory 
epithelium (Chuah and Au, 1991). The developing neural crest is a 
source of stem cells but these cells appear to be more restricted in 
their lineage commitment (Mujtaba et al., 1998) (Stemple and 
Anderson, 1993) (Kruger et al., 2002) and cannot differentiate into all 
types of CNS cells.
It is surprising that despite the existence of stem cells in the adult 
brain there is very little active repair after CNS injury. This may 
reflect inhibitory conditions of the mature CNS that suppress the 
development of mature CNS cells and/or the lack of a large enough 
stem cell pool whereby the generation of replacement cells is 
exceeded in number by cell loss.
The great attraction of neural stem cell grafts relates to their potential 
use for a number of different therapeutic purposes. They can form 
neurons that could either replace lost neurons in degenerative
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conditions, or act as relay bridges to restore circuits. If they formed 
glia they could act as bridges for axon regeneration, or replace 
oligodendrocytes and re-myelinate fibre tracts. Neural stem cells 
may also support axon regeneration through the secretion of 
neurotrophic factors (Lu et al., 2003) in animal models where axons 
are disconnected.
Protocols exist to expand the number of stem cells in vitro (Gottlieb, 
2002). Much hope is pinned on the possibility that they might 
respond to local tissue cues and differentiate exactly into the kind of 
tissue needed at the injury site or even migrate to it (Leavitt et al., 
1999;lmitola et al., 2004). Damaged areas in the CNS might release 
factors that attract and influence the development of stem cells. 
Since stem cells can turn into more than one cell type they have a 
theoretical advantage over simply transplanting a single more 
differentiated cell type.
Olfactory ensheathing cells
The olfactory system (Figure 1) is the only site in the central nervous 
system (CNS) where neurons and axons are continuously replaced 
during adult life (Huard et al., 1998;Graziadei and Graziadei, 1979). 
Specialised sensory neurons responsible for odour perception are 
located in the olfactory epithelium of the nasal cavity. The olfactory 
mucosa is a specialised pseudostratified epithelium made up of 
various cell types. The globose basal cells (a putative stem-cell)
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(Mackay-Sim and Kittel, 1991), sustentacular (supporting) cells and 
the olfactory receptor neurons represent the more important cellular 
elements of this system. The globose basal cells give rise to new 
neurons (Sicard et al., 1998;Murrell et al., 1996). These neurons 
migrate apically in the epithelium where they extend one apical 
dendrite and a basal axon. On their way from the olfactory mucosa 
to the olfactory bulb neurites have to grow through the basal cell 
layer and connective tissue and traverse the cibriform plate of the 
ethmoidal bone. From there they continue within the bundles of 
olfactory nerves, enter the olfactory bulb and finally establish 
synapses in the glomerular layer of the olfactory bulb. When air­
borne molecules are inhaled and carried in the air-stream to the 
nasal cavity they come into contact with the olfactory receptor cells. 
Smell is perceived whenever a specific group of molecules is 
recognised by the ciliated dendrite triggering an action potential that 











Figure 1 Schematic representation of the olfactory 
system.
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The olfactory system is the only site in the central nervous system 
(CNS) where neurons and axons are continuously replaced during 
adult life
The olfactory mucosa is divided into an epithelium and a lamina 
propria. The epithelium is separated from the underlying lamina 
propria by a basal lamina (BM). The main cellular constituents of the 
epithelium are the horizontal (HBC) and the globose basal cell (GBC) 
and the sustentacular cell (SC). The lamina propria is made up of 
loose connective tissue. Typical cellular constituents are fibroblasts 
and cells associated with blood vessels and also macrophages.
Olfactory receptor neurones (ORN) are located in the olfactory 
epithelium of the mucosa (M). Their axons traverse the lamina 
propria of the mucose and then the cribriform plate (CP) and 
eventually form synapses in the glomeruli (G) of the olfactory bulb 
(OB).
Olfactory ensheathing cells (OEC) accompany and ensheath 
olfactory nerves along their path from the mucosa to the bulb. When 
the olfactory nerve is injured they also provide guidance channels for 
regenerating axons. The globose basal cell (GBC), a putative stem 
cell (Goldstein and Schwob, 1996), gives rise to new neurones.
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The olfactory nerve fibres are accompanied and ensheathed by a 
unique Schwann cell-like cell type, the olfactory ensheathing cell 
(OEC). This cell is found beneath the olfactory epithelium in the 
lamina propria (Au and Roskams, 2003). Rather than enfolding 
individual axons, like a non-myelinating Schwann cell, the OECs 
ensheathe whole bundles of olfactory axons and cover them to the 
glomerular layer of the olfactory bulb. Olfactory neurones subjected 
to damage die at once and are immediately replenished from the 
stem cell pool. The regeneration of their axons to the olfactory bulb 
is associated with OECs. Local OECs provide a guidance channel 
for regenerating olfactory axons. They do not migrate or divide under 
these circumstances (Li et al., 2005), a feature that sets them apart 
from Schwann cells involved in the repair of damaged peripheral 
nerve. Olfactory neurones only have a short life-span and the 
turnover rate is about 28 days (Graziadei and Graziadei, 1979). 
Experiments aimed at obliterating the olfactory mucosa or olfactory 
bulb have demonstrated the enormous potential for self-repair in the 
olfactory system (Chuah et al., 1995). This unique ability of the 
olfactory system for self-regeneration drew the attention to OECs as 
potential candidate repair cells in CNS injury. OECs were able to 
achieve axon regeneration in a dorsal root transection model 
(Ramon-Cueto and Nieto-Sampedro, 1994). Just like Schwann cells 
OECs induce axon elongation but unlike Schwann cells they also 
allow re-entry into the CNS both in the olfactory bulb and in the 
dorsal root (Li et al., 2004). Experiments at our laboratory
22
demonstrated that it is possible to regenerate the severed 
corticospinal tract in the spinal cord by micro-injecting OEC 
suspensions into the lesion site (Li et al., 1997;Li et al., 1998). Other 
groups were able to corroborate these findings (Ramon-Cueto et al., 
1998). Whereas Schwann cell transplants induce highly tortuous 
axons with interspersed varicosities and multiple branching points, 
OECs recruit axons running in well-aligned parallel fascicles. And 
although axons in the olfactory system are unmyelinated, OECs are 
capable of myelinating axons in the spinal cord (Imaizumi et al.,
1998). Most importantly, OECs facilitate actual host re-entry of 
axons, the crucial prerequisite for functional recovery. Rats that had 
been given OEC grafts regained forepaw reaching function after 
spinal cord lesions (Li et al., 1997). More recent experiments have 
shown that even elementary functions like breathing can be restored 
following transplantation of OECs to lesions in the cervical spine (Li 
et al., 2003). Most researchers use OECs from the glomerular layer 
of the olfactory bulb but OECs can also be found in a clinically more 
accessible location, namely the olfactory mucosa where they are 
derived from a precursor cell (Chuah and Au, 1991) in the mucosa. 
Both cultured OECs from the olfactory mucosa as well as pieces of 
lamina propria promoted functional recovery and axon regeneration 
in spinal cord transection (Lu et al., 2001). Delayed studies using 
these cell types some time after causing the spinal cord injury were 
likewise successful (Lu et al., 2002;Keyvan-Fouladi et al., 2003).
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OECs are derived from the olfactory placodes. Without using 
purification procedures (as in this study), OEC cultures contain 
contaminating cell types, principally meningeal cells. The olfactory 
ensheathing cells resemble Schwann cells and express several 
typical Schwann cell markers such as p75 and S100. They also 
express GFAP and weakly express fibronectin. Meningeal cells 
express fibronectin strongly and fail to react with p75. OECs and 
meningeal cells co-operate in remyelination. Meningeal cells often 
enclose bundles of OEC-myelinated axons, an arrangement 
reminiscent of the perineurium seen in peripheral nerves (Lakatos et 
al., 2003b). A similar interplay between Schwann cells and 
fibroblasts is involved in the formation of the perineurium of 
peripheral nerves. The signalling molecule Desert Hedgehog (Dhh) 
is secreted by Schwann cells and controls the organisation of the 
surrounding connective tissue (Mirsky et al., 1999). Dhh is also 
strongly expressed by transplanted OECs (Smith et al., 2001). Both 
OECs and Schwann cells are capable of myelinating axons as 
demonstrated by the presence of Po mRNA , the gene for the major 
peripheral myelin protein. Despite the fact that there are no 
myelinated axons in the olfactory system OECs are able to myelinate 
axons in spinal cord injury models.
Both OECs and Schwann cells express an impressive range of 
neurotrophic factors (Boruch et al., 2001;Taylor and Bampton, 
2004;Friedman et al., 1999) and respond to the same growth-
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promoting molecules in culture. However, in specific culture 
conditions, Schwann cells (Mirsky et al., 2002) unlike OECs (Lipson 
et al., 2003) have been shown to express also neurotrophin 3 (NT3).
Despite these obvious similarities between them, OECs and 
Schwann cells seem to differ in their response to CNS injury. 
Schwann cells increase sprouting at the lesion site while OECs, in 
contrast, reduce sprouting and promote host re-entry. Transplanted 
OECs also appear to have superior migratory abilities in the CNS 
than Schwann cells. Most notably are the differences observed 
between OECs and Schwann cells when they come in contact with 
host astrocytes. In the olfactory bulb OECs co-exist with astrocytes 
unlike the peripheral nervous system which is devoid of astrocytes. 
Both OECs and astrocytes contribute to the glia limitans in the 
olfactory bulb. In CNS injury, OECs seem to suppress astrogliosis 
whereas Schwann cells induce astrocytic hypertrophy. Moreover, 
Schwann cells induce apoptosis in astrocytes. In culture, OECs 
freely intermingle with astrocytes and even migrate into areas 
containing astrocytes (Lakatos et al., 2000). Although Schwann cells 
are able to migrate across astrocytes monolayers they generally 
avoid contact with astrocytes and induce hypertrophy in astrocytes, 
corresponding to the in vivo situation. OECs and Schwann cells 
transplanted into the uninjured white matter of the adult rat spinal 
cord evoke very different reactions. Transplanted OECs lead to a 
milder expression of GFAP and chrondroitin sulfate proteoglycans
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(Lakatos et al., 2003a) in the host tissue than do transplanted 
Schwann cells. OECs reduce the expression of proteoglycans, a 
group of growth-inhibiting molecules, in reactive astrocytes (Verdu et 
al., 2001) unlike Schwann cells that increase the deposition of 
proteoglycans at the lesion site (Plant et al., 2001). Much of the 
unique effects of OECs probably depend on direct cell-to-cell 
interactions. OEC-conditioned medium, containing OEC-specific 
neurotrophic factors, does not appear to stimulate neurite outgrowth 
of embryonic chick ganglia in culture whereas co-cultures with OECs 
do (Lipson et al., 2003).
The situation in vivo is probably more complicated since most culture 
studies were comparing pure OECs or Schwann cell cultures but 
there is evidence to suggest that mixed cell transplants have different 
properties from pure suspensions. It appears that the meningeal 
cells restrain the migratory behaviour of the OECs and that the two 
cell types together are more effective in axon regeneration than 
OECs alone. Recent experiments have also shown that pure 
cultures of OECs are less effective at remyelination than mixtures of 
this cell type with meningeal fibroblasts (Lakatos et al., 2003b).
The astrocytic response to injury
An important impediment to axon regeneration is the so-called ‘glial 
scar’, characterised by a reactive gliosis that forms in the wake of 
CNS injury (Silver and Miller, 2004). This scar is heterogeneous in
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its composition and made up of reactive astrocytes, macrophages, 
fibroblasts, oligodendrocytes, endothelial cells, leucocytes and 
various non-cellular elements in the extracellular matrix like 
proteoglycans (Asher et al., 2001) and a well-defined laminated basal 
membrane (BM) in the lesion centre (Reier and Houle, 1988). 
Fibroblasts derived from the meninges migrate to the injury site and 
aid in the formation of this basement membrane (Carbonell and 
Boya, 1988). The BM represents a well-defined extracellular matrix 
(ECM) with collagen IV and laminin as the main components (Timpl 
and Brown, 1996). The typical response to CNS injury is 
characterised by hypertrophy of both astrocytic cell bodies and re­
arrangement of their cell processes. Astrocytes actively migrate 
towards the injury site. They strongly express GFAP and interdigitate 
their processes (Norenberg, 1994). They also participate in the 
phagocytosis of cellular debris, occupy the spaces left behind by 
degenerating cells and together with fibroblasts reconstitute a new 
glial limiting membrane. In addition, astrocytes can also act as 
antigen-presenting cells (Dong and Benveniste, 2001) and present 
antigens in an MHC-restricted manner.
The significance of the astrocytic response to CNS injury has been 
validated by a number of experiments. The potential for axon 
regeneration depends to a great deal on the extent of CNS injury 
characterised by the astrocytic response. Cell suspensions of dorsal 
root ganglia neurones microinjected into the corpus callosum of rats
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were capable of extending neurites over a long distance provided the 
injection site was only minimally perturbed (Davies SJ et al., 1996). 
Fibre regrowth was reduced if, however, the injection procedure 
disturbed the cytoarchitecture profoundly (Davies SJ et al., 1999).
To improve regeneration various attempts have been made to ablate 
reactive astrocytes. Most ablation methods employed either 
chemical means (ethidium bromide) (Moon et al., 2000) or X- 
irradiation (Trotman et al., 2004). These experiments largely support 
the view that astrocytes impede regeneration and therefore that 
axons regenerate better in the absence of astrocytes. Recently, a 
more elegant method for the selective ablation of reactive astrocytes 
has been introduced. A transgenic mouse was created that had a 
thymidine kinase (HTK) gene inserted downstream of the GFAP 
promoter region. Reactive astrocytes activate the GFAP gene and 
thereby up-regulate the expression of the HTK enzyme. These 
animals were given systemic ganciclovir which was then converted 
into a cytotoxic metabolite by the HTK enzyme (Bush et al., 
1999;Delaney CL. et al., 1996). The reactive astrocytes were hence 
selectively destroyed by ganciclovir administration. The animals 
received stab wounds to the cortex and hippocampus. Expression of 
neurofilament M was increased in the path of the stab wound, an 
area that had become devoid of astrocytes. Interestingly, this area 
was also lacking neuronal cell bodies.
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To some extent, this scar tissue acts as a physical barrier that 
obstructs the growth of axons and blocks the diffusion of 
chemoattractive molecules from the injury site. Studies based on 
calculating the diffusion coefficients with tetramethyl ammonium- 
sensitive electrodes were able to demonstrate decreased diffusion in 
regions of astrocytic hypertrophy and increased chondroitin sulphate 
expression (Roitbak and Sykova, 1999).
However, the recent emphasis is on inhibitory molecules expressed 
by the extracellular matrix (Filbin, 2003). The available options are 
hence directed at removing these inhibitory molecules or inhibiting 
their effects. Various inhibitory molecules have been identified at the 
injury site. These include the chemorepellant semaphorin III (De 
Winter et al., 2002), chondroitin sulphate, keratin and the 
proteoglycan NG2 to name but a few.
One major class of inhibitory molecules found in the extracellular 
matrix are the chondroitin sulphate proteoglycans. Chondroitinase 
ABC is a bacterial enzyme that can cleave glycosaminoglycans from 
the chondroitin sulphate core. Experiments conducted in a crush- 
model of the dorsal column in rats treated with chondroitinase ABC 
revealed axon elongation originating from the sensory neurons in the 
dorsal root ganglia and cranial extension of the fibres for up to 4 mm 
in the spinal cord (Bradbury et al., 2002). In a similar fashion, the 
corticospinal fibres regenerated downwards from the site of injury.
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The basement membrane (BM) situated at the centre of CNS injury 
has been singled out as another target for pharmacological 
intervention. One of the major constituents of the BM is collagen IV 
(Coll IV) amongst about 50 other constituents like the proteoglycans. 
Coll IV is formed by an interaction of astrocytes with fibroblasts or 
endothelial cells. Coll IV forms a stable triple helix only after 
hydroxylation of newly synthesized collagen molecules. The 
deposition of Coll IV at the BM can be reduced by the topical 
application of a,a’(2,2’)-dipyridyl (DPY), an iron chelator, that inhibits 
a key enzyme in this process. This approach was successfully 
employed to lesions of the transected post-commissural fornix 
(Stichel et al., 1999c). Axons were able to traverse the injury site 
and elongate up to their normal target, the mamillary body. 
Astrocytes and their processes intermingled with the regenerating 
fibres. This technique also enabled transected nigrostriatal 
dopaminergic axons to reinnervate the striatum in adult mice and 
mice at postnatal age 14 suggesting that type IV collagen is required 
for the development of the fibrotic response to adult brain injury 
(Kawano et al., 2005). However, the same regeneration paradigm 
failed in the thoracic spinal cord (Weidner et al., 1999b).
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Myelin-associated inhibitory molecules
The normal function of oligodendrocytes is to envelope axons with 
myelin sheaths to provide electrical insulation and enable an 
increase in the propagation speed of action potentials along the 
Ranvier nodes. Myelin contains molecules that impede axon 
regeneration. In a landmark experiment (Schwab and Thoenen, 
1985) dissociated newborn rat sympathetic or sensory neurons were 
plated in the presence of sciatic nerve or optic nerve segments. It 
was then shown that dorsal root ganglions extended their axons 
across Schwann cells from the sciatic nerve but avoided contact with 
myelin and oligodendrocytes from the optic nerve (Schwab and 
Caroni, 1988). This observation gave rise to the concept that myelin 
was responsible for regenerative failure in the CNS. Mice immunised 
with myelin showed extensive regeneration of large numbers of 
axons of the corticospinal tracts after dorsal hemisection of the spinal 
cord and recovered certain hind limb motor functions (Huang et al.,
1999). Likewise, antisera taken from immunized mice were able to 
block myelin-derived inhibitors and promote neurite growth on myelin 
in vitro. Schwab identified two inhibitory protein fractions associated 
with myelin (Caroni and Schwab, 1988). An antibody raised against 
these proteins could overcome the inhibitory effects of myelin and 
oligodendrocytes. This antibody, called IN-1, was subsequently 
injected in rats subjected to experimental spinal cord injury (Bregman 
et al., 1995). The rats regained a degree of their normal function
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after the operation and about 5 % of the fibres regenerated across 
the lesion site. The molecules recognised by IN-1 were unknown for 
a long time. More recently, a gene named Nogo encoding an 
inhibitory molecule recognised by IN-1 has been discovered (Chen et 
al., 2000). The gene has 3 alternative isoforms, designated as Nogo- 
A, -B and -C  (Schwab, 2004). Nogo A has the strongest inhibitory 
properties and is highly expressed by oligodendrocytes but not by 
Schwann cells.
Rats that had undergone complete transections of the cervical 
corticospinal tract and were subsequently treated with the anti-Nogo- 
A antibody mAb IN-1 recovered their ability to perform precise 
forelimb and finger movements (Raineteau et al., 2001). Another 
specific monoclonal antibody (7B12) directed against Nogo A has 
been created. This antibody was successfully employed in a rat 
stroke model to improve forepaw function 24 hours after the initial 
lesion (Wiessner et al., 2003). Corticospinal fibres from the uninjured 
sensorimotor cortex crossed the midline in the cervical spinal cord 
and bypassed the lesion site. Their number correlated positively with 
the behavioural outcome. The antibody did not improve the size of 
the infarct volume. The results therefore suggest that an 
improvement in behaviour was solely the result of uninjured fibre 
tracts forming new synapses with spinal motor neurones, thereby 
establishing alternative pathways. More recently, the extensively 
used anti-Nogo-A antibody mAb IN-1 was effective in achieving axon
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growth through the lesion site in a primate model of unilateral 
lesioning of the thoracic corticospinal tract (Fouad et al., 2004).
Nogo, however, may not be the only inhibitory molecule recognised 
by IN-1. There are other yet un-identified inhibitory proteins 
associated with myelin (Filbin, 2003).
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Requirements for an assay system
Our experience with human olfactory bulb samples has shown that 
cells with similar properties to the rat OECs can be obtained from 
tissues removed surgically as part of another operation, or material 
up to several hours post mortem. However, neither source is 
abundant, and the numbers of cells obtained from a single human 
olfactory bulb, given its small size, is very limited, and would not be 
sufficient to repair any substantially sized human lesion. Therefore it 
is important to look for other sources of candidate repair cells. The 
olfactory mucosa is hereby of particular interest since it is easily 
accessible from a surgical point of view (Feron et al., 1998) and 
could be grafted into the same patient without the need for 
immunosuppression. Adult Schwann cells (ASCs) either genetically 
modified or enhanced with OECs could be another potential source 
for candidate repair cells, as could be certain stem cell populations 
like OECs derived from stem cells in the olfactory mucosa or the 
neural crest stem cells (NCSCs).
To carry out the large number of tests (ability to enhance 
regeneration, dose response, toxicity etc) needed to validate the use 
of any one of the many candidates for reparative cells and their 
enhancement, it is essential to have an assay system capable of 
screening various types of cells and procedures preparatory to the
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much more time consuming tasks of trying out these cells in 
microlesions of the corticospinal tract. Dissociated cell cultures such 
as dorsal root ganglia (Scott, 1977) and retinal ganglia cells (Baehr 
and Bunge, 1990) have been used in the past to investigate the 
properties of certain growth factors and cells like Schwann cells. Cell 
cultures, unfortunately, do not necessarily allow results to be related 
to the in-vivo situation, as the cellular elements are analysed in 
isolation from their environment in the living animal.
Any assay system would have to address a number of specific 
points. How well do transplanted candidate repair cells survive after 
transplantation? Do they integrate well into the host environment 
and are they aligning and co-operating with existing tissue 
structures? Do the transplanted cells display any migratory 
behaviour? What is the host response to the recipient cells? To 
what extent are axons recruited into the graft and what is their 
arrangement in relation to astrocytic processes and candidate repair 
cells? Do these fibres manage to leave the graft and re-enter the 
host environment? In addition, a number of other requirements need 
to be fulfilled by an assay system. Chief among them is the need for 
reliable and reproducible results that allow careful comparison of 
different candidate repair cells. Moreover, the assay system should 
enable quick screening of multiple cell lines.
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Creation of cell columns in the thalamus
The technique of stereotaxic microinjection of cells into the thalamus 
was originally introduced in this laboratory by Gary Brook (Brook et 
al., 1994;Brook et al., 2001). He demonstrated the possibility of 
laying a column of cells into the thalamus, thereby in effect creating 
an artificial white matter tract to support the recruitment of axons 
from the host CNS into the graft. He was able to study host axons 
entering the graft and their response to various cell types. The 
relative simplicity of this approach and the speed with which it can be 
performed lend itself ideally for use as an assay system to study 
various candidate repair cells. Operations on the spinal cord are 
time-consuming and require substantial technical expertise, whereas 
microinjections to the thalamus owing to its large size and 
accessibility can be accomplished in a short space of time. The 
microinjection technique is relatively atraumatic (Raisman et al.,
1993) and thereby largely avoids the negative impact of the glial scar 
on the regeneration process. Another important advantage is that 
the animals subjected to this procedure do not sustain any functional 
neurological deficits and hence do not require any special post­
operative care requirements. This screening assay only assesses 
the anatomical changes in response to cell transplantation. The 
behavioural tests can later be properly conducted in a spinal cord 
model once a suitable candidate repair cell has been identified by the 
assay.
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Transplanting human cells into the rat CNS
Translating animal studies into therapeutic approaches
Animal models can provide useful information on the reparative 
capacities of candidate repair cells. For potential clinical 
applications, however, one cannot automatically assume that the 
human counterparts of suitable animal candidate repair cells would 
also be able to accomplish fibre regeneration in humans. To bridge 
the knowledge gained from the animal model to actual clinical 
applications, it has become necessary to extend the thalamus model 
to human candidate repair cells. The most promising source for 
human candidate repair cells lies in the olfactory nasal mucosa, an 
area that is easily accessible to the ear nose throat surgeon and 
would allow auto transplantation of cultured cells into the site of CNS 
injury.
If it could be shown that human OECs from the olfactory mucosa 
provide the same benefits in the rat model as rat OECs of mucosal 
origin with regard to axon recruitment and fibre regeneration, then 
most likely the same cells would also work in humans. Unfortunately, 
such an undertaking does not come without certain difficulties since 
humans and rats are very different species and xenografts are 
quickly and forcefully rejected by the host immune system.
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Mechanisms of rejection in syngeneic, alio- and xenografts
The CNS has traditionally been regarded as an immunologically 
privileged site. Its unusual immunological status is explained in part 
by the blood brain barrier (BBB) formed by endothelial cells and 
astrocytes, the weak expression of major histocompatability complex 
antigens (MHC) of class I and II, the lack of a classical lymphatic 
drainage and strong anti-inflammatory properties of the brain 
parenchyma. However, this privilege is not absolute and allografts 
(Lawrence et al., 1990) and xenografts in particular are invariably 
rejected. Although a lymphatic drainage for the brain has not been 
described anatomically, tracer substances and cells that are injected 
into the brain are detected within a few hours to days in the deep 
cervical lymph nodes in rodents (Bradbury and Westrop, 
1983;Oehmichen et al., 1979). The cervical lymph nodes are 
capable of antigen-specific B-cell proliferation and antibody 
production in response to an intracerebral deposition of antigen 
(Larsson et al., 2001;Cserr and Knopf, 1992). The intact BBB is 
impenetrable to immunoglobulins and naive T-cells but activated T- 
cells can traverse this barrier (Wekerle, 1986). Furthermore, injury 
and inflammation disrupt the integrity of the BBB (Pachter et al., 
2003;Gloor et al., 2001) allowing the influx of molecules that would 
normally not cross the BBB.
Neural xenografts are generally quickly rejected by the recipient with 
perhaps one known exception; studies with human adult Schwann
38
cells (ASCs) in our laboratory (Li, unpublished observations) 
revealed survival of these donor cells in the rat spinal cord without 
the need for immunosuppression. These unexpected findings are 
supported by an earlier study in Wistar rats suggesting that both 
human ASCs and NSCs can survive without any overt signs of 
rejection for up to 10 weeks after implantation (Hermanns et al., 
1997). Experiments using xenogeneic grafts of mouse sciatic nerve 
to bridge excised segments of facial nerve in rat recipients (Choi and 
Raisman, 2003) demonstrated that short segments could lead to 
restoration of the blink reflex without the need for 
immunosuppression whereas immunosuppression was required to 
restore function in longer segments. These observations point at a 
low-grade rejection of Schwann cells by the host immune system. 
There are no reports in the literature that would explain this apparent 
anomaly. One has to assume that Schwann cells either have a lower 
immunogenenicity or that they are able to reduce the strength of 
rejection by some unknown mechanism. There are a few reports that 
ascribe immunomodulatory functions to Schwann cells (Bonetti et al., 
2003) (Colomar et al., 2003) which may account for the impaired 
immune response.
Grafts can be classified as syngeneic, allogeneic and xenogeneic. 
Syngeneic transplants are derived from the same animal or cloned or 
inbred animals with the same genotype. They only elicit a very weak
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non-specific inflammatory response that largely depends on the 
extent of tissue trauma and immunosuppression is not required.
The term allogeneic refers to tranplantation of tissue between 
animals of the same species. The need for immunosuppression 
depends on the extent of host-graft strain mismatch. Incompatability 
at both class I and II MHC loci leads to vigorous rejection (Mason et 
al., 1986;Lawrence et al., 1990).
Xenografts can be divided into concordant (between closely related 
species), and discordant grafts (between distantly related species). 
In general, the less two species are related to each other the 
stronger is the response by which the xenograft is rejected. In 
practise this means that mouse nerve cells will survive far better than 
porcine neurones transplanted into the rat CNS. It has been 
speculated that the poorer survival of discordant xenografts may be 
attributed to a higher susceptibility to humoral (antibody-mediated) 
rejection. As the xenograft becomes vascularised over time 
antibodies gain access to the graft. A study in normal mice and 
immunoglobulin deficient (IgKO) mice revealed better survival of 
embryonic porcine ventral mesencephalic cells in IgKO mice 
(Larsson et al., 1999). The majority of IgKO mice had surviving 
grafts for up to 4 weeks, whereas survival was minimal in control 
mice beyond the 4 day horizon. Interestingly, the late rejection 
response in IgKO mice was largely CD8 T-cell mediated.
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MHC class II antigens play an important role in xenograft rejection. 
This was shown in MHC class ll-deficient mice (Duan et al., 2002) 
serving as xenograft recipients for dissociated embryonic ventral 
mesencephalic tissue from Sprague-Dawley rats. All of the MHC 
class ll-deficient mice had surviving grafts in the striatum 4 weeks 
post-grafting. In contrast, only a few of the MHC class l-deficient 
mice exhibited surviving grafts and none of the wild-type mice had 
any surviving grafts. These results suggest that the indirect pathway 
of foreign antigen recognition mediated by host MHC class II 
molecules and helper T cells is crucial for the rejection response to 
intracerebral xenografts.
The importance of MHC may be surprising, since MHC antigens are 
scarcely expressed by neuronal cells in the CNS. However, class-1 
antigens are present on endothelial cells. Other investigations have 
demonstrated MHC class-ll antigens on microglia (Lawrence et al.,
1994) and astrocytes (Dong and Benveniste, 2001). Furthermore, 
MHC antigens are inducible by injury and surgical trauma. Neural 
xenograft cell suspensions are often not pure and contain 
‘contaminating’ cells like endothelial cells and microglia which are 
known to express MHC antigens. These non-neural cells are 
assumed to contribute to the immunogenicity of the graft. In an 
attempt to reduce the immune response to porcine donor tissue, 
microglial cells were removed with antibodies (anti-Gal) against the 
a-galactosyl epitope and complement (Brevig et al., 2001). This pre­
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treatment reduced the microglial content to 11-24% of the control 
group. Purified human CD4 T-cells were co-cultured with porcine 
embryonic brain cells. Human CD4 cells did not proliferate in 
porcine embryonic brain cells pre-treated with anti-Gal but did 
proliferate in a control culture treated only with complement. These 
experiments suggest that it is not primarily the neural cells but other 
accompanying cells that induce a strong immune response.
Similar observations were made in immunocompetent rats with 6- 
hydroxydopamine induced hemiparkinsonism receiving dissociated 
ventral mesencaphalic (VM) tissue from pig embryos pre-treated with 
anti-Gal and complement or medium and complement (control group; 
(Brevig et al., 2001). In five out of eight rats receiving pre-treated VM 
cells, a reduction of amphetamine-induced circling behaviour by 
more than 50 % was observed whereas improvement was not seen 
in the control group.
Xenograft rejection is mediated by T-lymphocytes which ultimately 
infiltrate the graft. The role of T-cells is supported by several lines of 
evidence; xenografts survive better in T-cell deficient hosts and in 
animals receiving immunosuppressive drugs like cyclosporine (CsA) 
and tacrolimus (FK506) (Castilho et al., 2000). Monoclonal 
antibodies directed against CD4+ T-cells prolong the survival of both 
concordant (rat fetal neocortex) and discordant (human fetal 
forebrain tissue) neural xenografts in a mouse model (Wood et al.,
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1996). These findings are consistent with previous investigations 
showing that the rejection of skin xenografts depends critically on the 
presence of CD4+ lymphocytes.
All the available data support the concept, that neural xenografts are 
predominantly rejected by the indirect pathway, whereby a foreign 
peptide is presented to T lymphocytes by an antigen-presenting cell 
in the context of self major histocompatability complex antigens 
(MHC) although the direct pathway (direct stimulation of T 
lymphocytes by foreign MHC) may also play also a role, at least in 
non-neural grafts (Chitilian et al., 1998). Graft antigens, in the form 
of cell debris and shed molecules, are drained to the cervical lymph 
nodes where they are processed by host dendritic cells and 
presented in the context of MHC class-l and class-ll molecules to 
CD4 and CD8 T-cells. CD4 T cells transform into helper T cells, 
which as their name implies, help to activate B cells and CD8 T-cells. 
CD4 T cells also turn into inflammatory cells that act on 
macrophages in the graft thereby initiating a delayed-type 
hypersensitivity-like response. CD8 T-cells become either cytotoxic 
cells, lysing cells bearing MHC class-l molecules on their cell 




The immune response to xenografts is characterised by the 
involvement of various immune cells over time as shown in a study 
with dissociated mesencaphalic tissue from syngeneic, allogeneic 
and xenogeneic origin transplanted into the striatum of adult rats 
(Duan et al., 1995). Hosts were sacrificed at 4 days, 2 weeks or 6 
weeks after surgery. Their brains were processed for MHC class I 
and II antigens, complement receptor 3 (CR3) antigens on microglia 
and macrophages, helper T-lymphocyte antigen-cluster of 
differentiation (CD4), cytotoxic T-lymphocyte antigen (CD8) and 
tyrosine hydroxylase immunohisto-chemistry.
Animals with syngeneic grafts expressed low levels of MHC class I 
and II antigens at all times. CR3 positive cells were initially found in 
the graft area but by 2 and 6 weeks their numbers had fallen and 
they were mainly located at the graft-host interface. The numbers of 
CD4 and CD8 immunopositive cells were low by 4 days and 2 weeks 
and fell to undetectable levels by 6 weeks.
Xenogeneic grafts displayed signs of rejection from an early stage 
onwards. These animals had not received any drugs to stem 
rejection. At 4 days post operation (post OP) small cavities were 
visible in a number of grafts and at 2 weeks and beyond scarring and 
necrosis became more apparent. At 6 weeks all transplants had 
become rejected. Large numbers of MHC class l-positive cells of
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round morphology were noted as early as 4 days post OP and 
continued to become more pronounced at the later time points. In 
contrast, MHC class ll-positive cells were low at 4 days post OP but 
increased markedly in number by 2 and 6 weeks. These cells 
displayed mostly round morphology in the graft and resembled 
microglia at the graft periphery. MHC class ll-positive Cells were 
often found in blood vessels located in close proximity to the graft. 
Perivascular cuffing by both MHC class I and MHC class ll-positive 
round cells was also observed. This was most pronounced by 2 
weeks after transplantation. Activated CR3-positive microglia and 
macrophages were seen at all time points. At 4 days there were only 
small numbers of lymphocytes but by 2 weeks grafts were heavily 
infiltrated with CD4 and CD8-positive T-cells. Perivascular cuffing 
was also noted.
Reducing graft rejection/ immunosuppression
Cyclosporine A (CsA), an inhibitor of T-cell activation (Masri, 2003), 
can delay and sometimes even completely abolish rejection. 
Previous studies have shown its effectiveness in neural 
xenotransplantation (Brundin et al., 1985). CsA is a cyclic 
polypeptide consisting of 11 amino acids produced as a metabolite 
by the fungus species Beauveria nivea. The CD4+ T-lymphocyte is 
the main target but CsA also affects CD8+ T-cells and the release of 
interleukin 2 (II-2) and other lymphokines. Similar properties have 
been ascribed to tacrolimus (FK 506), a more potent
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immunosuppressant than CsA. FK 506 was isolated from the 
Streptomyces tsukubaensis strain. It can inhibit 11-2 at concentrations 
almost 100 times lower than CsA. Like CsA it affects an early phase 
in the T-cell activation pathway but has chemically a very different 
molecular structure.
Both CsA and FK 506 act through inhibition of the T-cell enzyme 
calcineurin (Castilho et al., 2000). They form specific complexes with 
cytoplasmic molecules. Calcineurin is thereby prevented from 
dephosphorylating specific nuclear factors. As a result, further 
downstream of the cascade, T-cells produce insufficient amounts of 
interleukin-2 (II-2), a cytokine essential for full T-cell activation.
Recently, a new form of administration for FK 506 has been 
described for neural transplantation. Liposomes can be prepared 
and used as vehicle for FK 506 administration. Like CsA, FK 506 is 
nephrotoxic and neurotoxic in a dose-dependent manner. Lipid 
micelles offer a new way of reducing these toxic side effects due to 
their altered biodistribution (Lee et al., 1995) (Ko et al., 1994).
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The fornix system as a potential assay system
The fornix (Stanfield et al., 1987) has some unique properties which 
lend itself ideally to the study of host re-entry and target re­
innervation. From an anatomical point of view, the fornix is a very 
accessible white matter tract with a well-defined projection. Tracers 
can be injected into the subiculum and followed all the way to its 
target area, the mamillary body. The tract represents essentially a 
unilateral projection from subiculum to mamillary body although it 
carries both afferent and efferent fibres at various points.
The fornix projects from the subiculum to the ipsilateral mamillary 
body. Fibres originating mainly from the septal two thirds of the 
subiculum extend obliquely over the surface of the hippocampus. 
These fibres unite in a bundle, the so-called fimbria. Once they 
have left the hippocampus, they become known as the columns of 
the fornix. At the anterior commissure the fornix splits into a 
precommissural component, which innervates various basal forebrain 
structures, among them the septal nuclei, and gives rise to the 
postcommissural tract which innervates predominantly the medial 
nuclei of the mamillary body. The projections to the mamillary body 
are topographically organised.
The arrangement of fibres in the fornix is very useful for lesioning 
studies. This has been demonstrated by Stichel who carried out
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transections of the postcommissural fornix in adult Wistar rats 
(Stichel et al., 1996). A tungsten wire was lowered stereotactically 
into the brain lateral to the left fornix at a distance of about 0.6 -  1.3 
mm proximal to the target, the mamillary bodies. The wire was 
extended 3 mm in a semicircle ventrally to the tract and withdrawn 
2.5 mm to sever the fornix. Finally, the wire was retracted and the 
knife removed. Immediately after transection animals received either 
a transplant of NSCs pre-labeled with a fluorescent dye or a DMEM 
injection as control. The cells were stereotactically injected into the 
centre of the lesion. Regenerating axons were anterogradely traced 
via injection of horseradish peroxidase into the subiculum. Animals 
were allowed to survive from 4 days up to 8 months. Stichel’s group 
observed a substantial fraction of fornix fibres emanating from the 
proximal fornix stump and traversing the lesion site to re-enter host 
territory and advance toward their normal target, the mamillary body 
(Stichel et al., 1996). In all animals that displayed regeneration, 
labelled cells were found extending from the injection site to the 
target area. Regenerating fibres persisted for up to 8 months 
following the grafting procedure.
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Material and Methods
Culturing and preparation of candidate repair cells 
Adult Schwann cells
Schwann cells (ASCs) were isolated from adult peripheral nerve and 
maintained in tissue culture by a modification of the method 
described by Morrissey (Morrissey et al., 1991). Sciatic nerves were 
dissected out from adult AS rats and transferred into a Petri dish 
containing phosphate buffered saline (PBS) enriched with antibiotics 
(penicillin and streptomycin, internal store) and rinsed 4 more times 
by transfer to the next Petri dish with above solution. Subsequently, 
nerves were cut into small pieces of about 1 mm with a tissue 
chopper and then placed in a culture dish containing growth medium, 
Dulbecco’s Modified Eagle Medium (DMEM, Gibco) with 10 % foetal 
calf serum (FCS, internal store) and 1 % antibiotics
(penicillin/streptomycin, internal store)). Initially, only fibroblasts were 
migrating out of the explant. When the outgrowth around the 
explants had reached a near-confluent monolayer, the explants were 
transferred (1. passage) to a new culture dish. After 2 weeks 
explants were passaged once more. Mostly ASCs migrated from the 
explants 6 weeks after starting the cultures. Explants were then 
placed in 60 mm Petri dishes and incubated overnight in growth 
medium (DMEM with 15 % FCS containing dispase I (1:6, Roche 
Molecular Biochemicals) and collagenase (0.5 %, Sigma)). The
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following day explants were dissociated by gentle trituration. 
Dissociated ASCs were then washed out with medium and 
centrifuged at 1200 revolutions per minute (RPM) for 5 mins. The 
pellet was re-suspended with growth medium and centrifuged a 
second time. The pellet was re-suspended, triturated and the cells 
finally plated down in the culture dish. Medium was replaced after 2 
days by a chemically defined medium (Verdu et al., 2000) to limit 
fibroblast proliferation. ASCs were ready for transplantation once 
they had grown to confluence.
Olfactory ensheathing cells
Olfactory ensheathing cells (OECs) were isolated from adult olfactory 
bulbs and cultured according to a modification of the method 
described by Ramon-Cueto (Ramon-Cueto and Nieto-Sampedro, 
1992). Olfactory bulbs were removed from adult AS rats and 
collected in PBS. The glomeruli were dissected out from the bulbs 
under the microscope and transferred into 60 mm dishes. Glomeruli 
were washed in PBS and then incubated with 0.1 % trypsin for 15 
min. Cells were re-suspended in growth medium (DMEM-F12/ 
Glutamax with 10 % FCS and antibiotics) twice thereafter. DNAse 
was added, the cells triturated and centrifuged for 5 min at 1200 
RPM. Cells were then plated down and the above medium was 
changed initially after 4-5 days and thereafter every 3-4 days. 
Passaging times varied according to cell density in culture.
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Neonatal Schwann cells
Neonatal Schwann cells (NSCs) were obtained from neonatal day 1- 
2 rat pups and cultured by a modification of the method described by 
Brockes (Brockes et al., 1979). Rat pups were culled by decapitation 
and both sciatic nerves were removed and collected in L-15 medium 
(Gibco). The nerves were cut into small segments of about 100 pm 
with a tissue chopper and incubated for 30 min with a solution 
containing trypsin (0.1 %, Sigma) and collagenase (0.03 %, Sigma) 
to digest the extracellular matrix. Digestion was stopped by 
triturating the cells with a solution containing 30 mg of bovine serum 
albumin (BSA, Sigma), 5 mg of trypsin inhibitor (Sigma) and 20 pi of 
DNAse (Sigma) in 10 mis of Hank’s Balanced Salt Solution (HBSS, 
Gibco).
In the next step the cell suspension was centrifuged at 1200 RPM for 
5 mins. The supernatant was removed and the cells re-suspended in 
1 ml of growth medium (10 % foetal calf serum (FCS) in DMEM 
(Gibco) enhanced with a 1 % solution of antibiotics (streptomycin/ 
penicillin, internal store)). Cells were triturated again, made up to a 
volume of 1.5 ml per dish in culture medium and plated down onto 35 
mm dishes. From the next day on, they were treated for 3 
consecutive days with cytosine arabinoside (Sigma) to eliminate 
fibroblasts. After about 6 days NSCs were ready for transplantation.
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Human and rat ensheathing cells from the olfactory 
mucosa
Human OECs were obtained from biopsy samples taken from 
patients, after providing informed consent, who had undergone 
various surgical procedures including removal of skull base tumours 
and naso-pharyngeal carcinomas. All biopsies were taken from 
areas which were considered as unaffected by malignant growth at 
the time of surgery. Biopsies from the posterior region of the mucosa 
were collected in saline solution supplemented with antibiotics. All 
biopsy samples were later histologically examined; none of them had 
been infiltrated by tumour tissue.
Rat mucosal OECs were obtained from the olfactory mucosa of adult 
AS rats. Briefly, lamina propria from the dorsal part of the septum 
and the superior turbinates was dissected free after enzymatic pre­
treatment of the mucosa and collected in L15 (Invitrogen, UK) 
medium.
For tissues from both human and rat sources an identical cell culture 
protocol was followed. Olfactory mucosa was chopped and plated on 
to poly-D-lysine (PDL, Sigma; 10|ug/ml.) coated dishes and 
maintained in Dulbecco’s modified Eagle medium/ Hams F12 (50:50) 
(DMEM/F12; Invitrogen) with 10% FCS (DFF10) for 7 days. At day 
8, the medium was enriched with fibroblast growth factor-2 (human 
Recombinant FGF-2, R&D Systems, UK; 20ng/ml ). To generate 
enough cells for transplantation, cells were sub-cultured by
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trypsinising cells and re-seeding on to freshly PDL-coated dishes. At 
between 14-20 days in vitro, rat mucosal cells were prepared for 
transplantation.
For human material, it was necessary to freeze cells in cell freezing 
medium and store in liquid nitrogen so that they could be retrieved for 
transplantation when necessary. Frozen stocks of cells were thawed 
and re-suspended in excess DMEM/F12. After a brief spin at 300 g 
for 3 minutes, the pellet was re-suspended and the cells were plated 
to 100 mm PDL coated plastic dishes. The cells were fed with DFF10 
supplemented with FGF-2 and maintained under optimal conditions 
for use in transplantation.
Neural crest stem cells
Neural crest stem cells (NCSCs) were retrieved by dissecting out 
neural tubes from 10 !4 day old rat embryos as described by Stemple 
(Stemple and Anderson, 1992). Briefly, neural tubes from embryos 
were explanted on a dish coated with fibronectin. Culture medium 
contained chick extract to supplement growth factors. Neural crest 
cells migrated from the dorsal aspect of the neural tube explant onto 
the surface of the culture dish. The explants were removed from the 
culture dish after 24 hours and the migrating neural crest stem cells 
transferred to a fibronectin coated dish. The population was left to 
expand (passage 1) and then transferred to another dish for further 
expansion. This procedure was repeated three more times until 
passage 4 had been reached. The population density was
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deliberately kept low to prevent cells from differentiating. Cells were 
examined under phase contrast and an estimate of the three main 
cell lineages derived from NCSSs was made.
Foetal brain cells
Pregnant AS rats were culled by intraperitoneal injection of 0.5 ml 
phentobarbitone, an approved Schedule I killing method. Uterine 
horns were removed by caesarean section, dissected free from their 
blood supply and the peritoneum, and immediately stored in ice-cold 
L-15 (Leibovitz 15) solution with added antibiotics.
Individual uterine horns were incised with a microscissor and 
embryos of age 14 to 15 were delivered by gentle compression of the 
uterine horns. An incision was made to separate the upper half of 
the head (roughly above the level of the future skullbase) from the 
lower half of the head, the body and the trunk, which were 
subsequently discarded.
The brains were stripped of all their coverings; the precursor 
structure to become the future skull and the meninges, characterised 
by their rich supply of blood vessels. The brains were then washed 
two more times in L-15 to rinse off tissue debris.
A modification of an established protocol at this laboratory to obtain 
cortical neurons from embryos at age 18 to 19 was used for further 
processing. Briefly, up to three brains were pooled and placed under
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a tissue chopper to yield tiny pieces of brain in the order of 100 pm 
by 100 pm.
The tissue pieces were placed in a 60 mm dish and incubated at 37° 
C in a filter-sterilized solution of 10 ml of Earls balanced salt solution 
(EBSS) containing 60 mg papain, 10 mg cysteine, 100 pi EDTA 
solution and and 20 pi p-mercaptoethanol. The reaction was 
stopped 30 min later by adding 10 ml of growth medium (with horse 
serum), 20 pi of DNAse (Sigma) and 10 ml of filter-sterilized DMEM 
containing 10 mg chicken egg white trypsin inhibitor and 2 mg 
DNAse. The solution was gently shaken and then spun down in a 
centrifuge for 5 min at a speed of 1200 RPM. The supernatant was 
removed and discarded. Finally, after adding 1 ml of growth medium 
the tissue was triturated with a Kwill tube and a 5 ml plastic syringe 
followed by a fire polished Pasteur pipette. Cells were counted, re­
suspended in L-15, centrifuged another time and subsequently, after 
removal of the supernatant and addition of a small volume of L-15, 
stored on ice before being grafted into the host.
Labelling with green fluorescent protein
Selected cultures of OECs and NCSSs were transfected for 24 hours 
with an adenovirus (gift of Dr Doorbar in Virology, NIMR) carrying the 
sequence for GFP. The cultures were further processed as 
described previously. Tissue had to be routinely perfusion-fixed to 
avoid leakage of GFP into the surrounding tissue.
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Preparation of cell suspensions
For transplantation, the following procedure was followed for both rat 
and human OECs from the olfactory mucosa. Subconfluent cells 
were digested with trypsin. After inactivating trypsin in DFF10 and 
triturating cells to give a single cell suspension, the total cell count 
was estimated using a haemocytometer. Following a brief spin (300g 
5 min), the pellet was re-suspended using DMEM/F12. One further 
spin in DMEM/F12 was necessary to remove traces of serum. Pellet 
was resuspended in DMEM/F12 and transferred to an Eppendorf 
tube and kept on ice. An overall cell yield of 8-12 x106 was obtained.
All other cell suspensions were prepared by replacing culture 
medium with Hanks’ balanced salts devoid of Ca++ and Mg+ ions to 
reduce cell adhesion to the dish. Thereafter, cultures were exposed 
in the incubator for 2 min to 0.125 % trypsin. The reaction was 
stopped by adding medium (according to the cell type used) 
containing 10 % FCS. The cell suspension was then transferred into 
a tube for centrifugation (Econospin, Sorvall Instruments, DU Pont) at 
1,000 RPM for 5 min. Following centrifugation, DNAse was added at 
a concentration of 1:100 to the cell suspension to reduce cell 
aggregation, the suspension was triturated and cells were counted in 
a haemocytometer chamber. Medium was added and the cells spun 
down a second time. The volume was then made up to a final 
concentration of approximately 1 x 108 cells/ml. Cell suspensions 
were kept on ice prior to grafting.
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All cell types were transplanted into the adult rat thalamus at a 
concentration of 100 x 106/ml. NSCs and OECs were grafted into the 
postcommissural fornix at the same concentration of 1 x 108/ml.
Immunosuppression of xenograft recipients 
Oral cyclosporine
Oral cyclosporine (CsA) at a concentration of 100 mg/L (a 250 ml 
ampoule of CsA was dissolved in 2.5 L tap water) was contained 
within the drinking water freely available to the rats. This is based on 
an average daily fluid consumption of 100 ml/kg bodyweight or 20 
ml/day in a typical 200 mg rat yielding 10 mg CsA/kg.
Intraperitoneal cyclosporine
Intraperitoneal CsA was administered at a concentration of 15 mg/kg 
bodyweight. Injections commenced 24 hours before surgery and 
continued on a daily basis for the lifetime of the animal.
Liposomal tacrolimus
The preparation of liposomal tacrolimus was based on the protocol 
described by Alemdar (Alemdar et al., 2001). 100 mg tacrolimus 
(Fujisawa Inc), 2.5g phospholipon 90 H (Natterman Phospholipid 
GmbH/ Rhone-Poulonc), 250 mg cholesterol and 2.5 ml absolute 
ethanol were mixed and heated to 55-60 °C. The components were 
mixed with 47.5 ml of normal saline. The preparation underwent 5
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freeze/thaw cycles to achieve a spontaneous pre-formation of 
liposomes. Liposomes were sized by filtration through a filter with a 
pore size of 0.45 pm. This solution yields a concentration of 
tacrolimus of 2mg/ml.
To achieve a final concentration of tacrolimus of 1 mg/ml in the cell 
suspension, OECs from the human mucosa were mixed with 
liposomal tacrolimus at a ratio of 1:1. Likewise, The final solution for 
intraperitoneal injection was diluted 1:1 in normal saline.
Animals received 1mg tacrolimus per kg bodyweight i.e. 0.2 ml for a 
typical 200g rat. Injections commenced 1 day prior to surgery and 
continued on a daily basis for the lifetime of the animal (2 weeks). 
The cell suspension was stereotactically grafted into the thalamus as 
previously described.
For control purposes, a cell culture with human OECs was treated 
with liposomal tacrolimus at a concentration of 1 mg/ml (equal parts 
of liposomal tacrolimus and medium). The culture was derived from 
the same preparation and was at the same stage as those cultures 




All animals were deeply anaesthetised by intraperitoneal injection of 
Avertin. Avertin was prepared by mixing 2 g of 2,2,2-tribromethanal 
(Aldrich Chem Co., USA.) and 2 ml 2-methylbutan-2-01 and adding 
100 ml distilled water and 8 ml absolute ethanol. Avertin was stored 
at 4°C prior to use. Rats received 1 ml Avertin per 100 g body 
weight. The skin of the operating area was shaved, disinfected with 
70 % alcohol and the rats mounted in a stereotaxic frame.
Extrusion of columns in the thalamus
The scalp was incised, the bone exposed by removing periosteum 
and a burr hole made according to the chosen co-ordinates. The 
edge of the burr hole was then cleared of sharp bone fragments and 
the dura carefully lifted up with a pair of fine forceps and opened to 
expose the underlying brain.
A micropipette with an internal diameter (Figure 2) of approximately 
300 pm was loaded with 3-5 pi of cell suspension. It was centred 2.5 
mm lateral and 3.3 mm posterior to the bregma aiming at the 
thalamus. The pipette was then lowered to a depth of 7 mm into the 
brain measured from the surface of the closed dura mater, and 
gradually withdrawn while injecting the cell suspension over a 
distance of 3-4 mm. The cell suspension was injected with the pulse 
generator set to a pulse frequency of about 1 pulse/sec and a pulse
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duration of about 0.1 sec. The generator controlled the air flow rate 
from the pressurised air cylinder via an electromagnetic valve. 
Following injection, the micropipette was left in situ for another 5 min 
to allow for pressure equilibration before the micropipette was 
carefully retracted
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Figure 2 Schematic representation of the steps 
involved in cell transplantation into the thalamus.
6 1
A. Preparation of tissue culture
Cells are cultured according to defined standard protocols. 
They go through several stages of feeding with growth 
medium and reseeding onto new plates (depending on the cell 
type used and the appropriate protocol) until a large enough 
number of cells has become available.
B. Preparation of cell suspension
Cells are enzymatically digested and finally processed into a 
cell suspension and stored in a small vial. The cell 
suspension is kept on ice until the final moment of 
transplantation.
C. Microinjection into the thalamus
The skull is surgically exposed and a burr hole is created 
using a stereotaxic frame. The pipette is loaded by aspirating 
3-5 pi of cell suspension from the vial. The pipette is then 
positioned according to the chosen co-ordinates and lowered 
into the thalamus. The cells are then deposited into the target 
area (the thalamus) by short-lasting pulses controlled by a 
pulse generator connected to a pressurised air cylinder. The 
pipette is left for 5 min in place before gentle retraction to 
allow for pressure equilibration.
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Generating a lesion and microinjection of cells into the
fornix
Animals were prepared for surgery and anaesthetised as previously 
described. The skull was exposed with a midline incision and the 
periosteum stripped off the underlying bone.
Radiofrequency heat lesions were generated with an electrode that 
was stereotaxically lowered to a point crossing the path of the 
postcommisural fornix (Figure 3). Prior to insertion the tip of the 
electrode was cleansed of debris and charred particles with a fine 
sand paper. The resistance of the electrode was determined in PBS 
solution and would typically be about 400 Q. The electrode was then 
mounted into the stereotaxic frame. The co-ordinates chosen for the 
centre of the radiofrequency heat lesion were 2.6 mm posterior, 1.0 
mm lateral and 8.6 mm ventral to the bregma. The co-ordinates 
were based on Paxinos’ atlas (George Paxinos, 1997) of the rat brain 
but had to be adjusted by trial and error to account for the different 
proportions of the female AS rats used in this setting.
A burr hole was made and the electrode lowered to its target point. 
The electrode was connected to a lesion generator (model RFG-3C 
RF, Radionics. INC. Cambridge, US) which allowed control of voltage 
and time and displayed resistance and wattage. The brain 
resistance at the target point varied from 4 kn to just above 5 kQ. 
Resistances above 5 kn were outside the displayed range of the
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lesion maker and prompted a message by the lesion maker 
indicating that the circuit was open. Despite this problem, it was 
possible in most case to initiate a current flow. A duration of 60 
seconds was found to give an acceptable lesion size in most cases. 
The resistance changed with the onset of current flow. It often fell 
initially, even for resistances outside the displayed range, to reach a 
plateau value but in some cases it rose again towards the end of the 
60 seconds period. The electrode was then withdrawn, removed 
from the stereotaxic frame and replaced by a micropipette. The 
micropipette was readjusted with reference to the bregma and loaded 
with the cell suspension. The micropipette was lowered into the 
brain but only to a depth of 8.4 mm to allow the cell suspension to fill 
the cavity left behind by the electrode. A volume of 2 pi was slowly 
injected and the micropipette left in situ for another 5 min to allow for 
pressure equilibration. Finally, the micropipette was gently retracted. 
A subgroup of animals only received cell suspensions but no lesion 
and yet another subgroup received the cell suspension 2 weeks after 
lesioning.
The fornix was labelled by injecting the subiculum with 2 pi of a 10 % 
solution of the tracer biotin dextran (BD, Molecular Probes Inc, US). 
In the initial stages the labelled animals had only a lesion. For the 
main experiments, BD-labelling was performed shortly after the 
radiofrequency heat lesion had been generated, and the cell
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suspension had been injected. In later experiments, animals were 
labelled at the time of delayed grafting.
The chosen co-ordinates were 6.4 mm posterior, 3.5 mm lateral and 
4.2 mm ventral to the bregma. As for the cell suspension, the tracer 
was slowly injected and the pipette left in place for several minutes 
before it was retracted.
For surgical procedures on the fornix, the preparation of NSCs and 
OECs suspensions and cell suspensions from 14 to 15 day old 
embryos followed the protocols outlined previously.
Skin closure and recovery
Skin and scalp were sutured with 4.0 Vicryl and the animals allowed 
to recover from anaesthesia under a warm lamp to prevent 
hypothermia. All animals were carefully checked for vital signs and 
adverse reactions following surgery until they had regained 
consciousness.
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Figure 3 Surgery on the post-commissural fornix.
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The diagram is a schematic representation of the fornix system.
A radiofrequency heat lesion (A) is generated to interrupt the post- 
commissural fornix (pathway highlighted by red colour).
Cells (B) are microinjected into the lesion site, either immediately or 
after a delayed and specified period of time.
The surviving and regenerating fornix fibres (C) are labelled by 
microinjection of biotin-dextran (BD, green colour) into the subiculum. 





All animals were culled under terminal anaesthesia by intraperitoneal 
injection of 0.5 ml Euthanal (Pentobarbitone). Following apnoea, a 
cruciate incision with a scissor was made into the abdominal wall just 
below the ribcage to provide access to the diaphragm. The lateral 
edges of the diaphragm were incised on both sides to gain access to 
the chest cavity. The incisions were then upwards extended, cutting 
the rib cage open and leaving a ribcage flap in the middle which 
could then be hinged back on itself. The chest cavity was now fully 
exposed. Clamps were applied to the descending aorta and the 
apex of the heart was nicked with fine scissors. A cannula with a 
syringe attached was gently advanced into the left chamber until the 
cannula became lodged into the ascending aorta. Perfusion could 
then begin. All protocols commenced with the perfusion of 100 ml of 
PBS over a 5 min period. Blanching of the ears and eyes indicated 
successful filling of the vascular system with PBS.
At the end of the perfusion procedure the skin over the skull was 
incised and the head separated from the trunk. The skull was then 
further cleared of skin and muscle attachments. The skull was 
subsequently removed piece by piece to gain access to the 
underlying brain. Finally, the dura was removed and the brain cut 
into a small tissue block. The orientation of the tissue block
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depended on the surgical procedure used, i.e. a frontally oriented 
block was required for thalamus operations and a sagittal block was 
necessary for fornix procedures. Further processing depended on 
the chosen perfusion protocol.
Simple PBS perfusion
This was the initial method of choice for samples destined for simple 
light microscopy. The animals were intracardially perfused with 100 
ml PBS over 5 min using a syringe. Brains were removed and frozen 
in dry ice. Unprocessed frozen tissue blocks were stored at -80° C.
Perfusion with 4% paraformaldehyde
This was the initial protocol for animals that had received fornix 
operations. Perfusion fixation rather than simple PBS perfusion was 
always necessary for animals that had received cells labelled with 
green fluorescent protein (GFP) to prevent GFP from leaking into the 
surrounding tissue. Samples obtained through this procedure could 
only be cut on the vibratome and could not be much thinner then 25- 
50 pm.
Animals were intracardially perfused, initially with 100 ml of PBS 
followed by 4 % paraformaldehyde over 30 min. Paraformaldehyde 
was drained from a bottle situated about 80 cm above the level of the 
sample. From there it drained via gravity into a plastic tube attached
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to the cannula lodged into the aorta. A small valve allowed 
adjustments of the perfusion rate. Following perfusion, brains were 
cut along the desired plane and trimmed to a smaller size. The 
trimmed blocks of brains were stored overnight in 4 % 
paraformaldehyde and processed the next day.
Perfusion with 4% paraformaldehyde suitable for cryostat 
sections
This procedure overcame the shortcoming of the previous one, 
allowing 10 pm sections and obviated the need for immediate tissue 
sectioning. The procedure followed the steps outlined above but the 
tissue block was re-immersed in 10 % sucrose (in a PBS solution) 
after an overnight storage period in 4 % paraformaldehyde. Once 
the sample had sunk to the bottom of the container, it was immersed 
in 20 % sucrose until it had stopped floating again and then quickly 
frozen in dry ice.
Tissue sectioning 
Cryostat sections
Coronal sections of 10 pm thickness were cut on a cryostat (Leica 
CM3050). Frozen sections were mounted on coated slides and air- 
dried for 30 min. They were stored at 4°C over a short period of time 




50 urn coronal sections were cut on a vibratome (Leica VT1000S).
Staining procedures 
Staining for light microscopy
Sections were fixed in either acetic alcohol or 4 % paraformaldehyde 
for 30 min depending on the antibodies used. Paraformaldehyde 
was used in the majority of cases since it gave better results with the 
notable exception of p75 that gave clearer pictures with acetic 
alcohol.
Slides were washed in PBS followed by blocking in 5 % defatted milk 
in PBS, each step lasting 30 min. They were then incubated 
overnight at 4°C with the primary antibody. Antibodies were diluted 
in a solution of 0.05 % azide (NaN3) and 1 % BSA in PBS.
The following monoclonal primary mouse antibodies were used:
■ anti-glial fibrillary acidic protein (GFAP) diluted 1:400 (Sigma), 
a marker of rat astrocytes and glial cells
■ anti-low affinity nerve growth factor-receptor (p75) diluted 1:20 
(MAB 365, Chemicon), detects rat Schwann cells and 
Schwann-like OECs
71
■ anti-low affinity nerve growth factor-receptor (p75) diluted 
1:100 (MAB 5264, Chemicon), detects human Schwann cells 
and Schwann-like OECs
■ anti-nestin diluted 1:500 (MAB 353, Chemicon), a marker of 
immature neuroepithelial cells of rat and mouse origin; detects 
Schwann cells and OECs
■ anti-human mitochondria (MIT) 1:300 (MAB 1273, Chemicon); 
stains the mitochondria of all human cells
■ anti-S-100 (Sigma) 1:1000
The following polyclonal primary rabbit antibodies were used:
■ anti-neurofilament L 1:500 (the 70 kD lightchain, Serotec)
■ anti-neurofilament H 1:500 (the 200 kD heavychain, Serotec), 
the 2 anti-neurofilament antibodies were always used in 
conjunction to stain nerve cells and their axons
■ anti-fibronectin (Chemicon) 1:500
■ anti-nestin 1:500 (Chemicon), reacts only with human nestin
The following polyclonal goat antibody was used:
■ anti-peripherin 1:200 (Santa Cruz Biotechnology Inc, US), 
marks mostly nerve cells of peripheral origin and a few cells of 
central origin
Sections were washed for 40 min the following day and incubated for
30 min with a secondary biotinylated antibody directed against the
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primary antibody used (Vector Laboratories Ltd). The anti-mouse 
secondary antibody was diluted 1:300 and the secondary anti-rabbit 
antibody was diluted 1:500. Following a further 30 min wash, 
sections were incubated with avidin-biotin complex conjugated with 
horseradish peroxidase (Vectastain ABC Kit, Vector Laboratories 
Ltd.). After a last washing cycle in PBS slides were transferred into 
acetate buffer and then visualized using the glucose oxidase-nickel 
3,3-diaminobenzidine (DAB) method. Where required, slides were 
counterstained with neutral red or thionine. Finally, slides were 
dehydrated in ascending concentrations of ethanol, defatted in 
Histoclear (Novara), and finally mounted in DPX mounting Medium 
(Raymond A Lamb Ltd.).
Staining for confocal microscopy
Sections were washed, and subsequently incubated overnight with 
the primary antibodies (mouse and rabbit in conjunction) and 0.2 % 
Triton in antibody diluent (1 % bovine serum albumin and 0.05 % 
azide in PBS). The primary antibodies were used at the same 
concentrations as for light microscopy processing.
In the second step, slides were washed several times again and then 
simultaneously incubated with two different fluorochrome-conjugated 
secondary antibodies depending on the primary antibody:
■ Alexa 488 goat anti-rabbit IgG 1:500 (A-11008, Molecular 
Probes, Inc)
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■ Alexa 546 goat anti-mouse IgG 1:500 (A-11003, Molecular 
Probes, Inc)
■ Alexa 568 donkey anti-goat 1:500 (A-11057, Molecular 
Probes, Inc) for samples where anti-peripherin had been used 
as primary antibody
No primary antibody was required for immunostaining the BD- 
labelled fornix. Instead, streptavidin, Alexa Fluor 647 (S-21373, 
Molecular Probes, Inc) with its known affinity for biotin was employed 
in the second step together with another secondary antibody.
Slides were examined under the fluorescence (Zeiss Axiophot) and 
the confocal microscope (Leica TCS SP). Selected slides were 
counterstained with DAPI (4’,6’-diamidino-2-phenylindole 
dihydrochloride) diluted 1:1000. Confocal images were digitally 
captured for up to 3 different wavelengths across the thickness of the 
sample. Vibratome sections (50 pm) were usually scanned in 5 pm 
increments and frozen sections (10 pm) in 2 pm increments. Channel 
colours were arbitrarily selected for any given wavelength. Coloured 
images were finally overlaid to aid in assessing the relationship of 
differently stained tissue structures. Images were stored on standard 
write-once compact discs.
Staining for markers of immunorejection
10 pm frozen sections were cut and mounted on to slides. Frozen 
sections were gently fixed for 5 min in 96 % alcohol and washed
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several times in PBS over a 30 min period. Slides were then pre­
incubated with horse serum diluted in PBS at a concentration of 1:30.
The following monoclonal mouse antibodies from Serotec (Oxford, 
UK) were used for detection of immune cells at a concentration of 
1:100:
■ anti rat class I (OX-18), recognises rat MHC class I antigen
■ anti l-A mouse/rat (OX-6), recognises MHC class II antigen
■ anti rat CD4 (W3/25) recognises the CD4 receptor expressed 
by helper T-cells and to a lesser degree by microglia and 
macrophages
■ anti rat CD8 (OX-8) recognises mainly the CD8 receptor 
expressed by suppressor T-cells
Slides were incubated for 1 hour at 4°C with above primary 
antibodies and subsequently rinsed with PBS for 30 min. Thereafter, 
they were incubated with secondary biotinylated horse anti-mouse 
antibody at a concentration of 1:300 for 1 hour at 4°C. After another 
30 min PBS wash cycle, slides were covered with avidin-biotin 
complex conjugated with horseradish peroxidase for 30 min, washed 
another 30 min in PBS and finally visualised with the DAB reaction as 




Only the ventral part of the column, lying in the lateral ventroposterior 
thalamic nucleus (VPL) in close proximity to the internal capsule was 
taken into consideration for a quantitative analysis. Sections were 
chosen if they clearly demonstrated the central part of the graft since 
fibres in this part of the graft were most likely recruited fibres. Slides 
showing numerous short axons without any apparent orientation 
most likely represented the area of the column/host interface and 
were therefore excluded. Axons in close vicinity to the graft/host 
interface that did not appear aligned to the direction of the column 
were also disregarded. The area of the column with the highest 
apparent density of axons was selected for counting. The width of 
the column at this point was measured and the number of axons 
counted that crossed an imaginary line representing this width. Axon 
density was defined as the number of axons per mm. The average 
axon density and the corresponding standard error of mean (SEM) 
for a given number of axons at survival times of one, two, and three 
weeks were calculated. The SEM was obtained by dividing the 
standard deviation by the square root of the sample size. The SEM 
was chosen since it is a measure of how close the sample mean is to 
the real population mean. For each column the longest axon was 
selected, and its length approximated by drawing a line connecting 




Columns extruded into the thalamus 
General observations
Columns were of consistent appearance in approximately 80 % of 
cases. Consistency was judged by uninterrupted continuity of the 
cell column and correct position in the thalamus. Extensive tissue 
damage was rarely seen in the thalamus, but in some cases a 
haematoma or cavity had formed at the entry point of the 
micropipette into the cortex. Neovascularisation was observed in the 
graft, as well as elongation and alignment of transplanted cells, and 
migration of cells along induced blood vessels. Blood vessels from 
the host entered the graft at various point to line up with the 
transplanted cells. Blood vessels were frequently branching and 
running slightly obliquely across the parallel bundles of cells.
Donor cells, host axons and astrocytic processes ran in parallel to 
each other in the graft. Astrocytic processes and axons were often 
intertwined with each other and followed the same path into the graft.
The following data are shown as mean value ± standard error of 
mean (SEM). The average width of the column measured 70.8 ± 3.4 
pm (n=119). The length of the column varied a lot and could not be 
precisely attained due to the fact that the column was often obliquely 
intersected by the section plane. However, based on measurements
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of the column visible on the slides, columns extended for a distance 
of up to 1.5 mm through the thalamus. The column ended in most 
cases in a round or ellipsoid bolus at its ventral end. Occasionally, 
cells had become dispersed along a disrupted tissue plane between 
the thalamus and the internal capsule, forming another column 
perpendicular to the main column.
All of the cell grafts investigated (olfactory ensheathing cells (OEC), 
adult Schwann cells (ASC), neonatal Schwann cells (NSC), neural 
crest stem cells (NCSCs) and human OECs) were able to recruit 
axons as demonstrated by immunostaining for NF. Axon recruitment 
was most pronounced at the ventral end of the graft. Also, grafts 
which accidentally lay more lateral extending into the reticular 
thalamic nucleus (RTN) generally induced ingrowth of a greater 
number of axons than grafts lying in the desired position, the ventral 
posterolateral nucleus (VPL), regardless of the cell type employed 
(Zhang et al., 1995). These transplants, however, had to be 
disregarded for counting, as they did not correspond to the desired 
position within the thalamus.
A control group of animals (n=5) that had only received medium 
(DMEM) but no cell suspension showed only small numbers of short 
axons within the column. The mean axon density (Figure 4) was 35 
±11.3 mm'1 at 14 days and the mean fibre length was 0.05 ± 0.01 
mm. These columns were generally very thin and often
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discontinuous. Given the thin width of the transplants and the short 
length of fibres it became difficult to decide whether fibres had 
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The control group of animals (n=5) had only received medium 
(DMEM) but no cell suspension. There were only small numbers of 
short axons within the column. Axons in the control group did not 
recruit any substantial number of axons. All cellular transplants led 
to the ingrowth of a larger number of fibres and this was shown to be 
statistically significant. The axons that were counted were probably 
artefacts derived from the periphery of the very thin columns.
(A) The mean axon density is about 35 mm'1.
(B) The mean axon length is about 0.05 mm. Error bars represent 
standard errors of mean.
Mean axon density and mean axon length are much lower in the 
control group than in all the groups that received a cell transplant.
81
mechanical or any other reasons. In normal cell grafts, it was 
relatively easy to identify fibres in the centre of the transplant and 
recognise genuine recruitment but in the thin control columns 
proportionally more fibres at the border of the graft were counted and 
this probably introduced a positive bias. Nevertheless, the control 
group provided some sort of benchmark measurement against which 
cellular transplants could be compared.
Olfactory ensheathing cells
Cell nuclei often looked oval and plump, and were scattered over the 
entire length of the column. Both subtypes of olfactory ensheathing 
cells (OECs) could be identified in roughly equal proportions by 
staining for p75 and fibronectin (Figure 5). The cells were all 
organised in parallel tiers and both astrocyte- and Schwann-cell like 
OECs freely intermingled with each other. Grafts were often 
observed to contain large numbers of cell debris and macrophages. 
OECs were capable of recruiting axons at the 7, 14 and 21 day stage 
(Figure 6). A number of grafts (Figure 7) failed to facilitate any 
ingrowth of axons and those grafts that did recruit axons were 
marked by only localised axon recruitment that did not extend across 
the whole length of the column. Axons were most numerous at the 
ventral end of the graft. Axon recruitment at 7 and at 14 days (Figure 
8) was sparse but had improved considerably in number by 21 days 
(Figure 9 and Figure 10). Axons and astrocytic processes were 
noted for their close spatial alignment (Figure 7 and Figure 10).
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Where axon recruitment had failed a paucity of astrocytic processes 
within the graft was also noted on a number of occasions (Figure 7). 
Not only astrocytic processes and axons were aligned but cells and 
axons also ran in parallel oriented tiers (Figure 9).
The axon density (Figure 11) increased from 29.3 ± 2.6 mm"1 (n=21) 
at 7 days and 31 ± 4.6 mm"1 (n=9) at 14 days to 91.4 ± 18 mm'1 (n=9) 
at 21 days post-operation. The mean length of axons (Figure 11) 
changed from 0.082 ± 0.007 mm (n=21) at 7 days and 0.138 ± 0.027 
mm (n=9) at 14 days to 0.108 ± 0.018 mm (n=9) at 21 days.
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Figure 5 Comparison of cell-type characteristics in 
mucosal OECs, NSC and bulbar OECs.
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Confocal images of olfactory ensheathing cells (OECs) derived from 
the rat mucosa (upper row: A,B>C), of neonatal Schwann cells 
(NSCs) (middle row: D,E,F) and OECs derived from the olfactory 
bulb (lower row: G,H,I). The scale bar represents 50 pm. All 
animals were culled at 14 days post-OP. Cell nuclei were marked 
with a blue-fluorescent dye (DAPI stain). The p75 Schwann cell 
receptor was stained with a red-fluorescent dye and the green 
marker shows the fibronectin distribution.
Cell nuclei (A) of mucosal-derived OECs are highly organised, of 
slender shape and run in parallel bundles. The fibroblast-like cells
(B) are fibronectin- and the Schwann cell-like OECs (C) are p75 (low 
affinity nerve growth factor receptor) -immunoreactive. Cells can be 
seen migrating away from the column.
Neonatal Schwann cells (NSCs) display a similar appearance: Cell 
nuclei (D) are well aligned. Fibroblasts (E) are fibronectin-positive 
and NSCs stain positive for p75 (F).
Cell nuclei of OECs from the bulb (G) are more oval in shape and 
look less organised. The staining pattern for fibronectin (H) and p75 
(I) is much like in the other 2 cell types.
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Figure 6 Axon recruitment by OEC grafts transplanted 
into the thalamus.
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Light microscopy of olfactory ensheathing cells (OECs). Animals 
were culled at 7, 14 and 21 days post operatively. Axon recruitment 
was detected by immunostaining for neurofilament (NF). Cell nuclei 
were counterstained with thionin. The scale bar represents 50 pm. 
The photographs show how nerve fibres are recruited by OECs.
A. At the 7 day stage NF-positive nerve fibres (arrow head) are still 
relatively short.
B. At the 14 day stage nerve fibres have become more abundant and 
an increase in fibre length can be noted. In addition, fasciculating 
bundles (arrow) of nerve fibres have emerged.
C. At 21 days post operatively, NF-positive axons (arrowhead) 
remain organised in fasciculating bundles (arrow). The axon 
arrangement is more irregular than in NSC grafts.
87
Figure 7 Comparison of axon recruitment by mucosal 
OECs, NSCs and bulbar OECs.
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Confocal images of olfactory ensheathing cells (OECs) derived from 
the rat mucosa (upper row: A,B,C), of neonatal Schwann cells 
(NSCs) (middle row: D,E,F) and OECs derived from the olfactory 
bulb (lower row: G,H,I). The scale bar represents 50 pm. All 
animals were culled at 14 days post-OP. Cell nuclei were marked 
with a blue-fluorescent dye (DAPI stain). The glial fibrillary acidic 
protein (GFAP) positive astrocytes and their processes were stained 
with a red-fluorescent dye and the distribution of neurofilament (NF) 
positive fibres was highlighted with a green fluorescent colour.
Olfactory ensheathing cells (OECs) from the rat mucosa: (A) NF- 
positive axons (arrowhead) run in parallel with the column, as do (B) 
GFAP-positive fibres originating from astrocytes (arrowhead). (C) All 
3 structures (axons, astrocytic fibres and cells) are aligned and 
establish contact with each other.
Neonatal Schwann cells (NSC) recruit more axons (D) than mucosal 
OECs and more astrocytic processes (E) enter the graft. The overlay 
picture (F) shows to what extent axons and astrocytic processes are 
intertwined with each other.
OECs from the bulb fail to attract any axons in this sample (G). 
Green spots mark the presence of autofluorescent macrophages. 
This OEC graft is also devoid of astrocytic processes (H). Cell nuclei 
(blue) appear scattered and disorganized. The overlay picture (I) 
demonstrates the lack of fibres and astrocytic processes in the graft.
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Figure 8 Comparison of axon recruitment by mucosal 
OECs, NSCs and bulbar OECs 14 days post 
operatively.
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Confocal images of olfactory ensheathing cells (OECs) derived from 
the rat mucosa (upper row: A,B,C), of neonatal Schwann cells 
(NSCs) (middle row: D,E,F) and OECs derived from the olfactory 
bulb (lower row: G,H,I). The scale bar represents 50 pm. All 
animals were culled at 14 days post-OP. Cell nuclei were marked 
with a blue-fluorescent dye (DAPI stain). The p75-positive cells 
were marked with a red-fluorescent dye and the distribution of 
neurofilament (NF) positive fibres was highlighted with a green 
fluorescent dye.
NF-positive Axons (A) are recruited into a column (B) comprised of 
p75-positive OECs derived from the olfactory epithelium. Both OECs 
and axons form a regular arrangement of parallel-running bundles
(C).
NSCs recruit axons at a high density (D) than OECs. The staining 
pattern of NSCs (E) is very similar to OECs of mucosal origin. Axons 
and NSCs (F) intermingle extensively.
OECs from the bulb (H) are seen in smaller numbers than the other 2 
cell types. OECs recruit only few axons (G). The overlay picture (I) 
demonstrates the spatial relationship between axons and cells.
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Figure 9 Comparison of axon recruitment by mucosal 
OECs, NSCs and bulbar OECs 21 days post 
operatively.
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Confocal images of olfactory ensheathing cells (OECs) derived from 
the rat mucosa (upper row: A,B>C), of neonatal Schwann cells 
(NSCs) (middle row: D,E,F) and OECs derived from the olfactory 
bulb (lower row: G,H,I). The scale bar represents 50 pm. All 
animals were culled at 21 days post-OP. Cell nuclei were marked 
with a blue-fluorescent dye (DAPI stain). The p75-positive cells 
were marked with a red-fluorescent dye and the distribution of 
neurofilament (NF) positive fibres was highlighted with a green 
fluorescent dye.
At 21 days post-OP all cell types facilitate axon recruitment (A, D, G) 
demonstrated by NF-immunoreactivity. Transplanted cells are 
identified by immuno-staining for p75.
OECs of mucosal origin (B) and NSCs (E) appear more organised 
than OECs from the bulb (H). The latter are also less numerous 
than the other 2 cell types. NSCs (E) are densely packed and 
aligned in regular parallel tiers; a feature that distinguishes them from 
the other 2 cell types. The overlay images (C,F,I) shows how cells 
and axons align in regular tiers in all 3 cell types.
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Figure 10 Comparison of astrocytic behaviour and 
axon recruitment in mucosal OECs, NSCs and bulbar 
OECs at 21 days post operatively.
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Confocal images of olfactory ensheathing cells (OECs) derived from 
the rat mucosa (upper row: A,B>C), of neonatal Schwann cells 
(NSCs) (middle row: D,E,F) and OECs derived from the olfactory 
bulb (lower row: G,H,I). The scale bar represents 50 pm. All 
animals were culled at 21 days post-OP. Cell nuclei were marked 
with a blue-fluorescent dye (DAPI stain). The glial fibrillary acidic 
protein (GFAP) positive astrocytes and their processes were stained 
with a red-fluorescent dye and the distribution of neurofilament (NF) 
positive fibres was highlighted with a green fluorescent colour.
Axons entering a graft made up of mucosal-derived OECs (A) are 
guided by (B) astrocytic processes. The overlay image (C) shows 
how both structures come in close contact with one another 
(arrowhead).
NSCs achieve a high degree of order; cell nuclei are elongated and 
spindle-shaped. Axons (D) run in parallel bundles and astrocytic 
processes (E) enter the graft at almost regularly spaced intervals 
(arrowheads) and align with the other structures (F) once they are 
inside the graft. The appearance of these astrocytic processes bears 
a resemblance to a branching tree.
In contrast, OECs from the bulb appear more disorganised but still 
manage to attract some axons (G). Astrocytic processes (H) stay in 
close contact with axons (I). Autofluorescent macrophages (green 




























Figure 11 Quantitative analysis of axon recruitment by 
olfactory ensheathing cells from the bulb.
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Olfactory ensheathing cells derived from the bulb (OECs) (A) attract 
small numbers of axons at 1 and 2 weeks post-OP and the actual 
axon density at this point in time is of the same order as in the sham 
group. However, at 3 weeks after transplantation fibre density has 
increased to about 90 mm"1.
Axon length (B) varies over the observed time period but stays close 
to 0.1 mm.
Error bars represent standard errors of mean.
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Adult Schwann cells
Adult Schwann cells (ASC) were capable of recruiting axons (Figure 
12). Abortive sprouting characterized by numerous short thickened 
axons turning away from the graft was sometimes seen at the 
host/graft interface. ASCs (Figure 12) only recruited small numbers 
of axons and sometimes no axons at all. The distribution of axons 
was often patchy and restricted to certain areas of the graft. The 
ventral end of the transplant was most successful at recruiting axons. 
At day 7 the mean axon density (Figure 13) was 53.8 ± 13.6 mm'1 
(n=15). At day 14 post operation (post OP) the average axon density 
was measured as 68.7 ± 9 mm'1 (n=13), and 63.1 ± 13.5 mm'1 (n=6) 
at day 21 post OP. The average maximal axon length (Figure 13) at 
day 7 post OP was 0.13 ± 0.024 mm (n=15), 0.139 ± 0.022 mm 
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Figure 12 Axon recruitment by ASC grafts in the 
thalamus.
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The photomicrographs are showing adult Schwann cells (ASCs) 7 
(A), 14 (B) and 21 (C) days after surgery and grafting of cell 
suspension. Axons have been marked with neurofilament (NF). The 
scale bar represents 50 pm.
The NF-positive axons (arrowheads) line up in parallel within the 
column. Only small numbers of axons are seen in these samples.

























Figure 13 Quantitative analysis of axon recruitment by 
adult Schwann cells.
101
Adult Schwann cells (ASCs) (A) recruit axons at a density of 50 -  60 
mm-1. The axon length (B) is about 0.13 mm. There is little change 
over the observed time period of 3 weeks for either the mean axon 
length or the mean axon density.
Error bars represent standard errors of mean.
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Neonatal Schwann cells
The survival of neonatal Schwann cells (NSCs) was superior to that 
of adult Schwann cells (ASCs). Their nuclei were mostly elongated 
and spindle-shaped, forming chains of cells and running in parallel 
with the direction of the column. All in all, the cell nuclei appeared 
highly organised and the cytoplasm of NSCs stained positive for low 
affinity nerve growth factor receptor (p75). An approximately equal 
number of fibronectin-positive (Figure 5) fibroblasts accompanied the 
NSCs. Both cell types intermingled freely. NSCs columns were 
characterised by their regular arrangement of cells in parallel tiers. 
Bundles of fasciculating NF-positive axons (Figure 9 and Figure 10 
and Figure 14) were recruited into the graft and seen along the entire 
length of the transplant. Some of the axons also displayed 
varicosities. Astrocytic processes were often seen to enter the 
column at almost regular intervals (Figure 10) and observed to 
establish close contact with axons (Figure 7 and Figure 10). All 3 
structures; astrocytic processes, axons and cells (compare Figure 7 
to Figure 10) were noted to run in parallel oriented tiers. Small von 
Willebrand factor-(vWF) positive blood vessels entered the column at 
various points to line up with the other structures within the graft 
(Figure 15). Blood vessels were also seen to enter the bolus and 
often divided into branches.
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The axon density (Figure 16) increased from 76.9 ± 5.6 mm'1 (n=6) at 
7 days and 91.7 ± 10.9 mm'1 (n=10) at 14 days to 126.7 ± 27.4 mm'1 
(n=3) at 21 days post OP. The mean length of axons (Figure 16) 
changed only slightly from 0.185 ± 0.03 mm (n=6) at 7 days and 
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Figure 14 Axon recruitment by NSC grafts in the 
thalamus.
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Neonatal Schwann cell (NSC) grafts 7 (A), 14 (B) and 21 (C) days 
post OP. Numerous NF-positive axons (arrow-heads) are seen. 
Axons extend throughout the graft. The axon density increases over 
time.
Scale bar represents 50 pm.
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Figure 15 Neovascularisation of the graft.
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Confocal images of olfactory ensheathing cells (OECs) derived from 
the rat mucosa (upper row: A,B*C) and neonatal Schwann cells 
(NSCs, middle and lower row: D,E,F,G,H,I) . The scale bar 
represents 50 pm.
All animals were culled 2 weeks after surgery. Cells immunoreactive 
for p75 are marked with the green fluorescent dye while von 
Willebrand factor (vWF)-positive blood vessels display red 
fluorescence. These images show the relationship of cells and blood 
vessels.
P75-positive OECs from the mucosa (A) form a column. The graft
(B) is supplied by (vWF)-positive bloodvessels. The overlay image
(C) shows the spatial relationship of OECs and blood vessels. It is 
apparent that blood vessels and OECs are aligned to some extent. 
The graft has not taken in all places and large empty spaces lacking 
a blood supply (arrowhead in C) are visible in the column.
Elsewhere, vWF-positive bloodvessels correspond to more cellular 
areas. Cells migrate away from the column along preformed blood 
vessels (arrow).
NSCs (D) survive better then mucosal OECs and the graft also has a 
more extensive blood supply (E). Cells and blood vessels align with 
each other (F).
In this sample, NSCs form a bolus (G) with blood vessels entering in 
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Figure 16 Quantitative analysis of axon recruitment by 
neonatal Schwann cells.
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Neonatal Schwann cells (A) recruit increasing numbers of axons over 
time up to a density of about 130 mm'1 at 3 weeks.
(B) The axon length varies little over time and stays close to 0.2 mm.
Error bars represent standard errors of mean.
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Olfactory ensheathing cells from the rat olfactory mucosa
Mucosal-derived OECs displayed spindle-shaped cell nuclei and 
p75- and fibronectin-positive cells were aligned in parallel strands 
(Figure 8). Axons (Figure 17) were seen in an equal distribution 
throughout most of the graft and integrated well in the graft. 
Astrocytic processes and axons intermingled with each other. 
Occasionally, astrocytic processes appeared to provide a guidance 
structure to axons (Figure 7 and Figure 10) enabling axons to run 
piggybacked into the centre of the graft. Axon recruitment was 
observed along most of the graft (compare Figure 7,8 and 9). Axons 
lined up between the tiers of cells. Columns were vascularised 
(Figure 15) by newly formed blood vessels originating from the host 
tissue. These blood vessels were seen to supply the column in a 
patchy distribution. Certain areas of the column were devoid of both 
donor cells and blood vessels. Newly formed blood vessels also 
provided a pathway for migrating donor cells to leave the column.
The axon density (Figure 18) decreased from 101.9 ± 16.1 mm"1 
(n=5) at 14 days to 79 ± 11.4 mm"1 (n=8) at 21 days post-operation. 
The mean length (Figure 18) of axons stayed practically unchanged 
at 0.156 ± 0.028 mm (n=9) at 14 days and 0.159 ± 0.029 (n=9) at 21 
days.
I l l
Figure 17 Mucosal-derived OECs 14 days post-OP in 
the thalamus.
112
Confocal images of mucosal-derived olfactory ensheathing cells 
(mucosal OECs). All animals were culled 14 days after 
microinjection of cells into the thalamus. Cell nuclei were counter­
stained with a blue-fluorescent dye (DAPI). The scale bar represents 
100 pm for the top row and 50 pm for the bottom row.
Mucosal OECs (A) recruit large numbers of NF-positive axons (green 
staining on all pictures). The fibres align with and often run in 
conjunction with GFAP-positive astrocytic processes (red 
fluorescence).
Same sample (B) showing p75-positive cells (red fluorescence) filling 
the column and attracting axons (green colour).
The high power magnification shows p75-im mu noreactive cells (C: 
red fluorescence) and nestin-positive cells (D: red fluorescence).




























Figure 18 Quantitative analysis of axon recruitment by 
olfactory ensheathing cells from the mucosa.
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Mucosal olfactory ensheathing cells (mucosal OECs: A) recruit fewer 
axons than NSCs. The mean density at 14 days is about 100 mm-1 
and falls to 80 mm'1 at 21 days.
The fibre length (B) stays constant at about 0.15 mm over the 
observed time period.
Error bars represent standard errors of mean.
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Olfactory ensheathing cells from the human olfactory 
mucosa
These animals were only investigated at the 7 and 14 days time 
interval. In the initial stages animals received only oral cyclosporine. 
However, this was not sufficient to suppress the loss of the grafted 
cells accompanied by the perivascular cuffing characteristic of 
immune rejection. The grafts became necrotic in a patchy 
distribution leaving islands of surviving tissue in between. Staining 
with mouse anti-human mitochondria monoclonal antibody (MIT) 
revealed a honey comb-like appearance of the cells but did not did 
not show the typical spindle-like shape of OECs. Recruitment of 
axons was rarely seen. The transplants were heavily infiltrated by 
both CD4 and CD8 positive cells. A typical sign of immunorejection, 
perivascular cuffing (Figure 19) of T-cells in blood vessels supplying 
the graft, was clearly seen in a number of grafts.
In contrast, transplanted cells survived better in rats receiving 
systemically administered cyclosporine. Human cells expressing MIT 
displayed the typical morphology of OECs; cells had a long spindle- 
shaped cytoplasm with an oval nucleus occupying most of the width 
of the cell (Figure 20). However, MIT was not always expressed 
across the whole of the graft although a number of nuclei had a 
shape suggestive of OEC-morphology. Generally speaking, MIT 
expression was localised to a few cells only. Axon recruitment was 
sparse (Figure 20) and varied along the course of the graft.
116
Mean axon density (Figure 21) increased from 49.9 ± 22.4 mm'1 
(n=5) at 7 days to 90 ± 10 mm"1 (n=2) at day 14. Axon length (Figure 
21) was comparable to the sham group (Figure 4) with 0.07 + 0.01 
mm (n=3) at 7 days and 0.06 mm ± 0.01 (n=2) at 14 days.
One graft (Figure 20 H) had formed in the potential space between 
the thalamus and the internal capsule as previously described for the 
other cell types. Despite large numbers of MIT-positive cells no 
axons could be identified in this particular graft.
Staining for immune markers revealed that systemic cyclosporine did 
not completely abolish the immune response against the xenograft. 
Mild infiltration by CD4 and (Figure 19) and CD8-positive cells was 
seen at 7 days but diminished (Figure 20 and Figure 22) by 14 days. 
Perivascular cuffing was never seen in systemically treated animals. 
MHC l-complex was only mildly detectable and diffusely expressed 
but MHC ll-positive cells were seen surrounding the graft in close 
vicinity. Most of the cells (Figure 22) expressing MHC-II complex 
had an appearance suggestive of microglia.
Experiments with liposomal tacrolimus were unsuccessful. All control 
cells in culture treated with liposomal tacrolimus died within a 48 hour 
period. No cells could be detected in any of the animals that had
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received cells suspensions mixed with liposomal tacrolimus. Only an 
empty cavity was found at the transplantation site.
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Figure 19 Immunorejection of human olfactory 
ensheathing cells in rats receiving oral or 
intraperitoneal cyclosporine.
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Photomicrographs of CD4 expression in animals receiving 
intraperitoneal cyclosporine for 1 week (A) and 2 weeks (B,C) 
following microinjection of olfactory ensheathing cells derived from 
the human olfactory mucosa into the rat thalamus.
Infiltration with CD4 is variable even among animals of the same 
survival time. Generally speaking, infiltration of the graft is strongest 
after 1 week (A) and becomes much reduced after 2 weeks (B,C) in 
animals having systemic immunosuppression.
In contrast, oral administration of cyclosporine fails to prevent 
perivascular cuffing (D; low magnification, E and F; high 
magnification), a hallmark of intense rejection.
Scale bar represents (A,B,C) 100 pm, (D) 200 pm, (E,F) 50 pm.
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Figure 20 Human OECs from the mucosa transplanted 
into rat thalamus.
121
Confocal images of olfactory ensheathing cells (OECs) from the 
human mucosa 14 days after microinjection into the rat thalamus. All 
animals received intraperitoneal cyclosporine. The scale bars all 
represent 50 pm.
Red fluorescent human OECs (B,F) identified by human anti- 
mitochondrial antibody (MIT) recruit small numbers of green- 
fluorescent axons (A,E). Both axons and OECs are sparse in 
numbers. The overlay image (C,G) depicts the relationship between 
cells and axons.
The bottom image shows a graft occupying the distal end of the 
thalamus (H) whereby the cells have extended horizontally along a 
weak tissue plane between thalamus and surrounding tissue rather 
than forming the typical bolus. Very few axons are recruited in this 
case even though large numbers of transplanted cell have apparently 
























Figure 21 Quantitative analysis of axon recruitment by 
human mucosal olfactory ensheathing cells.
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Human mucosal olfactory ensheathing cells (OECs) in animals 
receiving systemic cyclosporine recruit small numbers of axons (A) 
which seem to approach a density of about 100 mm"1 over time.
Axon elongation (B) is severely stunted and is indistinguishable from 
the control group.
Error bars represent standard errors of mean.
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Figure 22 Immune response to human OECs in rats 
receiving intraperitoneal cyclosporine.
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Photomicrographs of olfactory ensheathing cells (OECs) derived 
from the human mucosa 2 weeks after microinjection into the rat 
thalamus. Cyclosporine was systemically administered. The scale 
bar represents 50 pm.
In this sample CD4-positive T-cells (A) are not visible and only a few 
CD8-positive T-cells (B) can be detected. Expression of MHC I- 
complex (C) is undetectable in this sample and only weakly stained 
in other samples. MHC ll-positive cells (D), mostly of microglial 
origin, surround the graft.
126
Neural crest stem cells
Prior to transplantation, cultured neural crest stem cells (NCSCs) 
were examined under phase contrast (Figure 23) to assess cells for 
viability and to count their numbers. Approximately 20 % of cells 
displayed stem cell morphology, 10 % had a Schwann cell-like 
appearance and the remaining 70 % were identified as smooth 
muscle cells. Stem cells had a bow-shaped appearance, Schwann 
cells were spindle-shaped and smooth muscle cells were flat 
elongated cells characterized by multiple filopodia.
All of the following results were obtained from animals culled 2 weeks 
(n=8) after transplantation. NCSCs formed columns similar in 
appearance to the ones seen in grafts employing ASCs, OECs and 
NSCs. A bolus was commonly seen at the ventral end, just ending 
close to, or actually abutting the fibre tract of the internal capsule. A 
number of cells were observed expressing both neurofilament (NF) 
and peripherin, a marker for neurones of peripheral origin. These 
cells, therefore identified as neurons, were mainly situated in the 
bolus or at the ventral end of the column (Figure 24 and Figure 25). 
They neither expressed nestin nor any of the other markers 
characteristic for cells of NCSC lineage. Occasionally, axons were 
observed leaving the cell bodies of these neurons. Those axons were 
thick and usually only spanned a short distance. The column was 
characterized by densely packed cells with long processes 
intermingling with each other. These cells expressed both nestin
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(Figure 24 and Figure 25), an intermediate filament protein 
characteristic of immature neuroepithelial cells, and the glial marker 
p75. However, they did not express S-100. Although no double­
labelling with p75 and nestin was performed, distribution and 
morphology of the cells identified by these two antibodies were 
strikingly similar. Numerous delicate NF-positive axons were seen 
inside the column (Figure 25). They were thinner than the axons 
observed in any of the other cell grafts previously tested, ran over 
long distances and were evenly distributed throughout the graft. The 
precise origin of these axons could not be established. They did not 
seem to arise from the transplanted neurones of NCSC origin and 
were not expressing peripherin, the marker for neurones of 
peripheral origin. Occasionally, the course of the axons could be 
traced back to the area of the host/graft interface.
The graft/host interface did not show any significant difference to its 
appearance in ASC, NSC or OEC grafts. Glial fibrillary acidic protein 
(GFAP) positive astrocytic processes (Figure 25)) entered the graft 
and aligned themselves with p75 positive/nestin positive cell 
processes inside the graft. Astrocytic processes only expressed 
GFAP but not nestin. A close relationship between astrocytic 
processes, p75/nestin-positive cells and the fine NF-immunoreactive 
axons could be seen with the three components preferentially 
running in bundles. At times some axons would part from their
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original bundle only to intermingle with an adjacant bundle and follow 
its course.
NCSCs infected with a defective adenovirus (n=4) containing the 
DNA sequence for green fluorescent protein (GFP) were used to 
elucidate the differential fate of these cells in vivo. Approximately 80 
% of cells in culture labelled positive for smooth muscle actin (SMA). 
Most of the cells also expressed GFP. None of the cells were 
observed to express GFP within the column or the bolus following a 
survival time of 14 days. Cells in the column weakly stained for 
peripherin, indicating a neuronal fate. However, a cell type of very 
unusual morphology (picture not shown) was seen at the margin of 
the graft but just within the host neuropil. These large cells strongly 
expressed GFP with their processes radiating out in all directions. 
Some of the processes entered the graft. They did not express any of 
the markers characteristic for cells of neuronal or glial origin and 
could hence not be detected by labelling for p75, nestin, GFAP, 
S100, peripherin or SMA. It is worth mentioning that further 
experiments in our laboratory have shown the poor survival of GFP- 
transfected cells at the 2 weeks stage which is possibly related to 
toxic properties of the vector.
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Figure 23 Migration of neural crest stem cells.
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Schematic representation (A) of neural crest stem cells (NCSCs) 
migrating (arrows) from the neural tube (N) and differentiating into 
various tissue types.
The phase-contrast photomicrograph of an NCSC explant (B) at age
10.5 days (courtesy of Mrs. Harsha Jani) shows how migration also 
takes place in vitro. NCSCs proliferate and migrate (white 
arrowhead) in cell culture and have the potential to give rise to 
different cell types.
The scalebar represents 50 pm.
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Figure 24 Cell fate of neural crest stem cells grafted 
into the thalamus.
Photomicrographs of neural crest stem cells (NCSCs) grafted into the 
thalamus. NCSCs can either adopt a glial or a neural fate 
depending on environmental cues. The Scale bar represents 50 pm.
Glial cells (A) express nestin (black streaks). They are found in the 
column portion of the graft where they run in parallel bundles. Cell 
nuclei (red) are counterstained by neutral red.
In the bolus portion of the graft NCSCs are more likely to differentiate 
into neurones (B). These cells stain positive for peripherin, a marker 
predominantly expressed by neurones of peripheral origin, and often 
resemble dorsal root ganglia in their appearance.
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Figure 25 Axon recruitment by neural crest stem cells.
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Neural crest stem cells (NCSCs) 14 days after microinjection into the 
rat thalamus. Scale bar represents 100 pm (A,C) and 50 pm (B,D).
Neurones and axons are stained for NF (green fluorescence). Glial 
cells are detected by nestin expression (red fluorescence).
NCSCs (A) adopt both a neural (asterix) and a glial fate. Very fine 
axons (B) are attracted into the graft (arrowhead). These axons do 
not seem to be derived from neurones (asterix) of NCSC origin.
NCSCs (C) differentiate into glial cells expressing p75 (red 
fluorescence) and intermingling with GFAP-positive (green 
fluorescence ) astrocytic processes. (D) The staining pattern of 
these glial cells is similar for nestin (red fluorescence). Astrocytic 




It proved to be difficult to achieve a complete lesion transecting the 
whole of the postcommisural fornix (Figure 3). The lesion size was 
deliberately kept small not exceeding 1 mm in diameter to avoid a 
large gap in the fornix that might have had a detrimental affect on 
fibre regeneration. The initial experiments were therefore largely 
based on trial and error to optimise the size and position of the 
lesions. Due to the fact that the flexible electrode was not 
permanently mounted into the stereotaxic frame and had to be re­
adjusted for each use, a further element of variation was introduced 
into the experimental set-up.
Lesion and fibre tract could clearly be seen under low magnification 
in unstained sections and a preliminary selection of suitable samples 
was made at this stage.
In animals that had received pure lesions without grafting of cell 
suspensions, biotin dextran (BD)-labelled axons were halted and 
sprouted at the point were they came into contact with the lesion site 
(Figure 26). They displayed typical growth cone-like structures at 
their tips and the axons thickened in the vicinity of the lesion. In 
incomplete lesions intact fibres that closely passed the injury site 
responded by thickening but did not sprout towards the lesion. The
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injury site itself was characterized by significant and extensive tissue 
damage. A rim of fragmented pieces of tissue surrounded a 
homogenous necrotic core in the centre of the lesion. The periphery 
of the lesion counterstained stronger for neutral red than the 
surrounding intact tissue.
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Figure 26 Histological appearance of the intact and 
lesioned fornix.
The fornix (black stain) is a well-defined white-matter tract that 
projects from the subiculum via its postcommissural pathway (A) to 
the mamillary body (B). The radiofrequency heat lesion (C) is 
characterised by a central necrosis surrounded by a diffuse 
demarcation zone. Tissue damage is extensive. Fornix fibres (black 
stain) cannot advance past the lesion site and form bulbous 
extensions. Reactive sprouting is also visible.
The scale bar represents (A,B) 100 jum (C) 200 pm.
139
General appearance of fornix grafts
A total of 23 samples were further examined following processing 
and immunostaining. The samples were judged for general 
appearance, lesion quality, fibre ingrowth, cell organization and 
migration of cells. Of these, 8 lesions were apparently complete, 
another 8 were incomplete and in the remaining 7 samples the tract 
appeared intact but staining was too weak to evaluate the fibre tract 
unambiguously. The naked lesion (Figure 26) was characterised by 
a central necrosis surrounded by a diffuse demarcation zone. 
Extensive tissue damage was noted. Fornix fibres were incapable of 
advancing past the lesion site and formed bulbous extensions. 
Reactive sprouting was also visible.
The appearance of the cell transplants bore a clear resemblance to 
the thalamic grafts. Although not primarily intended, typically a small 
column had formed at the dorsal site of the lesion, which ended in a 
cell globus filling the lesion cavity. Just as in the thalamic columns, 
cells ran in parallel strands aligning with the column. The bolus 
contained numerous cells orientated in whorls and circular structures. 
The cells in the bolus did not align with the course of the 
postcommissural fornix.
BD-labelling proved to be a reliable way of tracing the fornix to the 
lesion site. None of the cell transplants were associated with fibre
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regeneration, neither into the graft nor beyond the lesion site. 
Although axons were unable to advance into the lesion site, cells 
were seen to migrate from the graft into the intact proximal and distal 
postcommissural fornix. These cells were properly aligned with the 
tract and intermingled with BD-labelled axons.
Neonatal Schwann cells
Neonatal Schwann cells (NSCs) (Figure 27) strongly expressed p75 
and survived well in the grafted areas. They often formed a short 
column with well-aligned cells extending into the bolus at the ventral 
end. Cells in the bolus were poorly organised and had a scattered 
appearance. In a number of cases NSCs were circularly oriented 
around the central necrosis. The centre of the bolus was devoid of 
cells and filled with an amorphous substance indicating a necrotic 
process. The cells attracted NF-positive axons into the column 
where they were aligned with the NSCs, as in the thalamus grafts. 
NF-positive axons of short length were even detected in the bolus. 
But NSCs failed to guide BD-labelled postcommissural axons into 
and past the lesion site. The fibres stopped abruptly at the point 
where they came into contact with the lesioned area, which had 
become occupied by the grafted cells. Axons in close proximity to 
the lesion became thickened, exhibited many varicosities and often 
ended in growth cone-like expansions. NSCs migrated towards the 
proximal fornix. They extended only for a very short distance into the 
proximal fornix and ran in parallel with the tract direction. The cell
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density was notably lower than in the bolus and p75 was less 
strongly expressed. A similar phenomenon was observed in the distal 
part of the fornix just past the lesion site. At the proximal end BD- 
labelled axons and NSCs came into contact with each other, forming 
an overlapping zone (Figure 27). In those grafts where the lesion 
maker had failed to disrupt the fornix completely NSCs were 
observed to become integrated into the fornix. It was impossible to 
decide whether these fibres were surviving fibres, which were merely 
surrounded by transplanted cells or newly regenerated fibres that 
had been attracted into the lesion area.
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Figure 27 NSCs grafted into the lesioned 
postcommissural fornix.
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Confocal images of neonatal Schwann cells (NSCs) from 4 different 
samples grafted into the lesioned post-commissural fornix 2 weeks 
after the procedure. Animals were labelled with biotin dextran (BD) 
immediately after lesioning and microinjection of cells. Scale bar: 
Top row: 100 pm. Bottom row: 50 pm.
Green fluorescent BD-labelled axons (A) fail to advance past the 
lesion/ transplant site. The grafted red fluorescent p75-positive 
NSCs (B) are typically arranged in a circular pattern around a central 
necrotic area.
NSCs migrate from the graft into both the proximal (C) and distal 
fornix where they line up and overlap with fornix fibres. Failure of 
disrupting the fornix (D) results in NSCs lining up with the tract 
direction and limited regeneration of fibres into the graft.
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Olfactory ensheathing cells
BD-labelled axons responded to OECs (Figure 28) just as they did to 
NSCs. The lesion site was completely impenetrable to fibres and 
postcommissural fornix fibres were never seen entering the bolus. 
However, NF-immunoreactive axons of unknown origin were seen in 
both column and bolus (Figure 28D). They ran in parallel bundles in 
the column-like part of the graft, whereas in the bolus they followed a 
more circular course. OECs migrated into the proximal and distal 
ends of the severed fornix and intermingled with the axons.
Delayed transplantation
Delayed transplantation did not confer any benefit in terms of 
regeneration. OECs transplanted 4 weeks after the original lesion 
failed to attract any fornix fibres into the lesion site.
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Figure 28 OECs transplanted into the lesioned fornix.
Olfactory ensheathing cells (OECs) grafted into the post-commissural 
fornix 14 days after surgery (A,B): Green-fluorescent biotin dextran 
(BD)-labelled fibres fail to enter the grafted cell bolus at the lesion 
site. OECs expressing p75 (red fluorescence) migrate into the 
proximal end of the fornix (more obvious in B).
The situation is unchanged (C) even 3 weeks post-operatively. 
Although BD-labelled purple-stained fornix fibres fail to regenerate 
(D) the p75-positive red-fluorescent graft manages to attract green- 
fluorescent NF-positive fibres of unknown origin.
Scale bar represents 100 pm except for B (50 pm).
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Foetal brain cells
Embryonic rat brain cells comprising neurones and glia (Figure 29) 
harvested 14 days after conception, failed to enable regeneration 
past the lesion site just like in the other cell types. They did neither 
express p75 nor GFAP in the centre of the lesion. DAPI-stained 
nuclei of different shapes and sizes could be detected. The cells had 
a heterogeneous distribution and differentiated into various cell 
types. They sometimes appeared to be organised in subpopulations. 
Interestingly, cells in close contact with the fornix expressed p75. 
This was most obvious in an incomplete lesion, where BD-labelled 
uninterrupted fibres ran alongside the bolus. Cells adjacent to the 
fornix expressed p75 weakly and diffusely.
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Figure 29 14 day old embryonic brain cells 
transplanted into the lesioned fornix.
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DAPI staining of 2 weeks old embryonic (E14) brain cells (A) 2 
weeks after microinjection into the fornix reveals heterogeneous cell 
populations. The approximate graft border (A,B and D) is marked 
by the white dashed line. The asterix lies within the graft. The scale 
bar represents 100 pm except for C (50 pm).
Red-fluorescent E14 cells (B) express p75 (arrow) when they migrate 
into the fornix. E14 cells only express p75 (C, red fluorescence) 
when they come in close contact with the fornix fibres (green 
fluorescence).
The transplant in the centre (D) expresses neither GFAP nor p75. 
NF-positive fibres (red fluorescence) are likewise not seen within the 
graft. The graft centre is devoid of any NF-positive fibres but fibres 
can be seen elsewhere corresponding to the normal anatomical 
appearance of the host.
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Statistical results
The following self-explanatory Table 1 provides a summarised view 
of all measurements obtained for the different transplant groups. The 
specific data were discussed in the previous sections in relation to 
each candidate repair cell type. The table is split into 2 subtables; an 
upper section relating to the mean axon density and a lower section 
relating to the mean axon length. The columns represent the time 
axis for life spans of 7,14 and 21 days and the rows represent the 
various cells types further subdivided into sample size, mean and 
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Table 1 Overview of measurements
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Kruskal-Wallis Test
One of the most widely used tests in the biological sciences is 
Student’s t-test which allows a pair-wise comparison of sample sets. 
One may be tempted to use this test for comparison of multiple 
samples but the t-test is not suitable for higher degrees of freedom 
(ie. more than 2 samples to compare) and also assumes a normal 
distribution (data should not be skewed either) of the data sets. 
Analysis of variance (ANOVA) should be used to compare the means 
of groups of measurement data.
The sample sizes for my data were of unequal size and, by drawing 
simple histograms, some of them did not appear to correspond to the 
classical Gaussian Bell curve distribution. This ruled out a simple 
analysis of variance (ANOVA) test since it relies on normally 
distributed data and equal sample sizes and relatively homogenous 
variances.
To overcome this problem I applied the Kruskal-Wallis test (Rohlf and 
R.R.Sokal, 1995) which does not make prior assumptions about the 
distribution of the data set. It is mathematically identical to the Mann- 
Whitney U test but enables comparison of more than 2 groups. The 
underlying principle of the Kruskal-Wallis test (named after William 
Kruskal and W. Allen Wallis) is the transformation of all data into 
simple rank numbers (integer numbers from 1 to the last sample
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count) which are then redistributed to their respective sample group. 
Tied samples get average ranks i.e. if we had 4 samples with equal 
measurements occupying rank position 7,8,9 and 10 then 8.5 would 
be substituted for each measurement value (with ranks 7,8,9 and 10 
absent from the table). However, it is recommended that the test has 
not too many tied values. The effect of this rank transformation is 
that widely disparate numbers are hence more equally distributed 
and closer to each other. The variances of the rank means for the 
groups are then compared. The test statistic H is calculated and then 
compared with the critical value of the chi-square table for (k -  1; 
where k is the sample size) degrees of freedom for a given 
significance level.
The formula to calculate the test statistic is:
H = 12/(N(N + 1))* SUM(T2i/rii) - 3(N + 1) 
where H: test statistic
N: Highest rank
T: Total of rank numbers for each sample group i
r\\: Number of observations/ data for each sample group i
The null hypothesis Ho states that there are no expected differences 
between the mean ranks.
The null hypothesis Ho is rejected if H is larger then the critical value 
found in the chi-square table for the given significance level. A
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rejection of the null hypothesis Ho does not necessarily mean that 
there are statistically significant differences between all sample 
groups, it would be sufficient for one group to differ from the others. 
For this reason a pair-wise comparison may still be necessary.
The original table for the measured axon length in mm at 14 days 
post- operation was as follows:
ASC OEC NSC sham OEC mucosa human OEC
0.05 0.3 0.3 0 0.2 0.07
0.15 0.06 0.2 0.07 0.1 0.05
0.15 0.14 0.28 0.03 0.08
0.1 0.2 0.15 0.03 0.18









The rank-transformed table is as follows:
ASC OEC NSC sham OEC mucosa human OEC
5 39.5 39.5 1 34 11
25.5 8 34 11 16 5
25.5 20 38 2.5 13
16 34 25.5 2.5 31








Using the Kruskal-Wallis test:
Ti 259 186.5 331.5 22 131 17
Ti2 67081 34782 109892 484 17161 289
rii 12 9 10 5 5 2
Ti2/ni 5590 3865 10989 97 3432 145
Using the above values in the formula yields: 12/1806*24118- 
129=31.25
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The null hypothesis is hence rejected as this value exceeds the 
critical value from the chi-square table which is 20.52 for 5 degrees 
of freedom and a significance level of P = 0.001. This means the 
differences seen between the samples are highly significant.
The calculation for the different cell groups without the sham group 
is similar. However, I have used a special Excel spreadsheet 
(http://udel.edu/~mcdonald/statkruskalwallis.html) for the calculation 
(rather than the by hand approach used for the example) which gave 
slightly different results because the tied samples were adjusted in a 
different way.
I first compared all groups including the sham group for the 14 day 
period. The differences observed were highly significant. I then 
omitted the sham group for the comparison and found that the 
differences were still significant but to a lesser degree. This would 
support the view that the observed differences were not just 
statistically significant when compared to the sham group but that 
there were also statistically significant differences between the 
various cell types.
The spreadsheet calculation for axon length at 14 days gave an 
adjusted H of 41.65 for all groups (highly significant) and an adjusted 
H of 32.53 for cell types only (still highly significant). There was also 
a statistically significant difference between OECs and NSC (H=7.1)
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but this was not highly significant (p=0.008) and a comparison of 
OEC from bulb and mucosa yielded a test statistic of H=0.45 with 
p=0.5 which means that there was no significant difference between 
OECs derived from the bulb or the mucosa.
The spreadsheet calculation for axon density at 14 days gave an 
adjusted H of 31.04 for all groups which was highly significant and an 
adjusted H of 27.5 (still highly significant) for all cell groups. Inter­
group comparison of OECs and NSCs resulted in an adjusted H of
13.6 and this was statistically highly significant. Likewise differences 




The thalamus as a model 
General considerations
The thalamus proved to be a useful model for the study of cell 
survival, host response and axon recruitment. A large number of 
candidate repair cells could be investigated. The results varied to 
some degree as anticipated in a biological system but still allowed 
meaningful interpretation of the findings. Descriptive statistics of 
the cells clearly showed differences in axon recruitment but 
otherwise there were striking similarities between the cells with 
regard to staining pattern and astrocytic response. Interestingly, the 
shape of the nuclei and the appearance of axons were a better guide 
to cell identity than p75, nestin or fibronectin staining. The staining 
pattern was largely indistinguishable between the various candidate 
repair cells but the shape and organisation of nuclei provided some 
clues as to the origin of the cells. Fasciculating axons with 
varicosities were most commonly seen in neonatal Schwann cells 
(NSCs). Olfactory ensheathing cells (OECs) from the mucosa had 
the thinnest and longest cell nuclei. But even for the same cell type 
there was a considerable degree of variability in the shape of the 
nuclei.
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All the candidate repair cells were able to survive in the thalamus. 
Survival of candidate repair cells was, as expected, only a problem in 
xenografts. An interesting finding was that nestin and p75 stained 
Schwann cells and OECs in a similar pattern and this was clearly 
recognisable when adjacent sections from the same animal were 
examined. Nestin, commonly thought of as a marker of immature 
neuroepithelial cells, yielded a clearer and less diffuse staining 
pattern of the cells when compared to p75.
All cells were lining up in parallel with the column but cell nuclei were 
more organised and more elongated in NSCs and mucosal OECs 
than in bulbar OECs. All candidate repair cells but human OECs 
displayed migratory behaviour. The adjacent astrocytic scar 
response was only mild and did not differ significantly between the 
cells examined as would be expected from a lesion technique aimed 
at minimal disturbance of the host environment. Also, astrocytes 
(Wei et al., 2002;Lin et al., 1995) did not exhibit any signs of nestin- 
immunoreactivity in keeping with a low degree of activation.
The experiments have also shown that all candidate repair cells are 
able to recruit cells. NSCs stood out since they recruited both the 
largest number of axons and the longest axons. OECs from the 
mucosa came next in order with slightly less and shorter axons. But 
surprisingly, OECs from the bulb recruited only small numbers of
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axons of short length. In fact, measurements of the axon density at 1 
and 2 weeks were similar to the sham group.
Most likely, it is the exposure to neurotrophic factors that directly 
influences the length and number of axons. Younger cells like NSCs 
are more rich in neurotrophic factors and therefore provide better 
support for axons. The mucosal OEC may represent a younger 
version of the OEC (Au and Roskams, 2003) if one assumes that 
OECs of placodal origin arise from the mucosa in the adult animal 
and travel from there to the bulb while they undergo maturation. 
Alternatively, the mucosa may be the site of a putative OEC stem cell 
or OEC precursor cell (Chuah and Au, 1991) that may have given 
rise to less mature OECs in culture.
The method employed here to quantify the recruitment of axons is 
relatively simple and quick. The densest appearing group of axons 
within the graft is selected for counting. An imaginary line 
representing the width of the column is intersected by fibres which 
are then counted. It was my impression that axons are generally 
fairly evenly spaced but they do not always occupy the whole length 
of the transplant. The transplants are three-dimensional structures 
and the counting method used here is essentially one-dimensional in 
nature. This may introduce certain errors since the method heavily 
relies on the observer’s perception of the area of highest axon 
density. Three-dimensional reconstruction of the slices would
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theoretically have given more precise measurements since axon 
density may vary from layer to layer and it would have also taken into 
consideration the segmental distribution of axons favouring the 
ventral end of the column. In other words the method employed 
here is biased towards the best area of axon regeneration within the 
graft. Small localised areas of fibre recruitment are commonly seen 
in OEC grafts. In support of this method it can be said, that using a 
large enough sample size should have overcome the difficulty of 
selecting the most representative layer. The method was able to 
show a difference in axon density between OECs and NSCs in spite 
of a bias towards a higher density in OECs, where samples with a 
dense appearing area of axons that did not cover the whole of the 
column led to a potentially higher count. In other words, one might 
have expected an even greater difference between OECs and NSCs 
in reconstructed samples where the localised fibre recruitment 
observed in OECs related to the whole volume of the column would 
have potentially yielded very low counts.
Reconstruction would also have enabled a more accurate 
determination of actual axon length. Slices through tissue samples 
can be oblique in relation to the position of the column to varying 
degrees. Reconstruction would have helped to determine the 
direction of the fibres and measure their length more precisely. 
Again, one has to say that this error would lead to a shorter
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measurement of axon length on average but be overcome by the fact 
that all cell grafts are equally affected by this effect.
The poor performance of OECs for the first 2 weeks is evident not 
just from descriptive axon statistics but also from the histological 
appearance of the graft. There were a number of failed grafts and 
even where the grafts had been successfully taken, macrophages 
and scattered cells with large and plump nuclei indicated problems 
with cell survival and cell integration. This is an interesting 
observation because OECs are better than Schwann cells in 
facilitating axon regeneration is the spinal cord. The thalamic column 
assay measures different properties of the OECs and is not directly 
predictive of repair in the spinal cord. The thalamus assay reflects 
the recruitment potential of OECs whereas a successful outcome in 
the spinal cord model depends on nerve fibres re-entering the CNS. 
Different culture conditions may have also affected the regenerative 
potential of OECs. In fact, it is through the process of culturing 
(Raisman, 2001) that OECs gain their regenerative potential in the 
first place and it may therefore not be surprising if even slight 
differences in culture conditions yield cells with different properties.
Axon recruitment goes hand in hand with the ingrowth of astrocytic 
processes Astrocytic processes are mingling with axons and 
directing them into the graft where they become aligned with other 
structures (Brook et al., 2001). The important relationship between
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astrocytes and axons was apparent from all candidate cells 
examined. Failure of regeneration is also a failure of astrocytic 
processes entering the graft and providing support for axons. 
However, I was unable to establish a clear relationship between the 
extent of astrocytic scarring and the ingrowth of fibres. There 
appeared to be little difference in the amount of scarring between the 
different cell types observed. Since astrocytes are commonly viewed 
as responsible for the formation of an inhibitory glial scar impeding 
regeneration, this raises questions regarding their precise role in 
regeneration and points to a more complex picture.
The thalamus model does not lend itself to the study of axon re-entry. 
There is no clearly defined fibre tract that is suitable for labelling. 
Likewise, the origin of recruited axons is unclear although some 
evidence points at the reticular nucleus (RTN) (Vaudano et al., 
1998a) as the source of recruited axons. In all grafting experiments, 
axons were mainly seen at the ventral end of the column as one 
might expect from axons originating from the RTN. It would 
therefore appear that candidate repair cells selectively recruit axons 
from this area of the thalamus. This is in line with other observations 
suggestive of differential recruitment depending on the type of 
candidate repair cell employed. Schwann cells can regenerate 
specific fibre tracts in the CNS (Wunderlich et al., 1994) (Montero- 
Menei et al., 1992) but fail to restore the corticospinal tract (Li and 
Raisman, 1994).
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In the corticospinal tract OECs are the only cells that have been 
unambiguously shown to mediate regeneration of severed fibre tracts 
(Li et al., 1997;Ramon-Cueto and Nieto-Sampedro, 1994). 
Regeneration in the corticospinal tract results in axons re-entering 
the host and forming new synaptic connections with denervated 
target areas. There are a number of experimental models where 
OECs had no measurable effect on axon regeneration (Gomez et al.,
2003) (Nieto-Sampedro, 2003). Interestingly, OECs from the bulb 
also appear to perform worse than other cell types in the thalamus 
model. This could possibly be related to varying culture conditions, 
the environment at the transplantation site or a differential response 
of thalamic axons to these cells. The disorganised appearance of 
OECs, however, strongly points at adverse environmental conditions 
at the lesion site or a higher sensitivity of OECs to environmental 
factors. The age at which OECs were transplanted varied slightly 
and cultures took at times longer to arrive at the desired stage owing 
to differences in serum. Young OEC cultures were noted for their 
higher mitotic activity in culture and it is possible that less mature 
OECs secret higher levels of neurotrophic factors than older OECs. 
This view is partly supported by studies comparing neurite outgrowth 
in the presence of immortalised pure neonatal and adult OECs 
cultures (Goodman et al., 1993). In these studies neonatal OECs 
stimulated the growth of marginally longer neurites. Nevertheless, 
the differences found were only small and the cells were obtained by 
simian virus 40 (SV40) large T antigen transduction. Older cultures
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of OECs had a higher proportion of fibroblasts but also were more 
likely to contain dying OECs. It is hard to believe that culture 
conditions alone should account for the differences observed 
between OECs and NSCs since culture conditions were also varying 
to some degree in the other cell lines. The actual transplantation 
procedure and the host site must also play an important role. On the 
other hand, the possibility that culture conditions might be more 
crucial for OECs than other repair cell lines cannot be completely 
ruled out. It is possible that OECs from the bulb produce 
neurotrophic factors at lower concentrations than other candidate 
repair cells. It is their ability to enable severed nerve fibres to re­
enter the uninjured host tissue that sets them apart from other 
candidate repair cells and forms the prerequisite for functional 
recovery. Many studies support the view that OECs exert their 
effects through direct cell-to-cell interactions (Lakatos et al., 2000) 
(Lakatos et al., 2003a) rather than through neurotrophic support. But 
in all likelihood the chief property measured by the thalamic assay is 
the neurotrophic support on nerve regeneration by the transplanted 
cells.
When given additionally to Schwann cell grafts, neurotrophic factors 
mostly failed to coerce axons into leaving the transplant but 
neurotrophic factors elicited stronger axon recruitment (Tuszynski et 
al., 1998) (Weidner et al., 1999a) into the grafts than Schwann cells 
alone did. These observations support the view that axon
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recruitment into the graft depends critically on the level of 
neurotrophic factors but exposure of axons to neurotrophic factors 
does not necessarily facilitate host re-entry.
Schwann cell-filled seed channels in a thoracic spinal cord 
hemisection model were claimed to achieve regeneration of some 
axons into the distal spinal cord (Xu et al., 1999). This model was 
further refined by direct infusion of BDNF and NT-3 into the spinal 
cord distally to the seed channels and enabled the re-entry of fibres 
into the distal host parenchyma (Bamber et al., 2001).
It remains to be seen whether OECs from the mucosa are even more 
effective in spinal cord repair since they recruit larger numbers of 
axons in the thalamus than bulbar OECs but are also expected to 
share common properties with OECs from the bulb. Theoretically, 
cells that enable host re-entry as well as provide strong neurotrophic 
support should be particularly effective in white matter tract repair.
Histologically, OECs, NSCs, ASCs, mucosal OECs and even NCSCs 
were indistinguishable by their staining pattern. All of them stained 
for p75 and nestin. If one excludes the NCSCs, which were not 
examined for fibronectin, then all of them (as none of them were pure 
cultures) contain cells that express fibronectin. The similarities 
between OECs and Schwann cells are striking and extensively 
supported by the literature (Wewetzer et al., 2002). Both cell types
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express Dhh (Smith et al., 2001), a molecule that regulates the 
formation of the epi- and perineurium and enables co-operation 
between Schwann cells and fibroblasts.
Evidence for differences between OECs and Schwann cells has 
come mainly from observations of axonal and astrocytic responses in 
culture and in vivo (Lakatos et al., 2003a). OECs naturally co-exist 
with astrocytes in the bulb. In culture, OECs freely intermingle with 
astrocytes (Van Den Pol and Santarelli, 2003) whereas Schwann 
cells induce astrogliosis and hypertrophy of astrocytes. Furthermore, 
Schwann cells and astrocytes are separated by basal laminae into 
distinct territories. OECs appear to act through a combination of 
direct cell-to-cell interactions and neurotrophic support (Li et al.,
2004) and it is assumed that it is the former mechanism that 
facilitates re-entry of host fibres.
OECs do not only promote fibre regeneration through direct cell-to- 
cell interaction and neurotrophic support they also appear to be 
involved in myelination of regenerating fibres. However, it has been 
suggested that the myelination seen after OEC transplantation is due 
to Schwann cell contamination. Several studies appear to support 
this claim. The investigators of one in vitro study (Plant et al., 2002) 
observed that OECs co-cultured with dorsal root ganglion neurons 
did not exhibit a Schwann cell-like relationship to axons and did not 
form myelin. In contrast, previous in-vitro studies studies have
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shown that OECs can myelinate dorsal root ganglion neurones 
(Devon and Doucette, 1995).
In vivo experiments have also yielded equivocal results. In one 
experiment, foetal rat OECs (Boyd et al., 2004) were labelled with a 
replication-deficient BAG retrovirus carrying the gene LacZ that 
encodes for the p-galactosidase enzyme. These LacZ expressing 
OECs were not found to make direct contact with axons but instead 
engulfed units of host-derived Schwann cells associated with axons. 
Another study (Akiyama et al., 2004), on the other hand, was able to 
show that Schwann cells and OECs in alkaline phosphatase- 
expressing transgenic rats were both associated with myelin 
formation in rats depleted of myelin by X-irradation and ethidium 
bromide. They could show that only the grafted alkaline 
phoshatase-expressing OECs or Schwann cells were responsible for 
myelination and not endogenous Schwann cells. Both the grafted 
Schwann cells and the OECs induced extensive remyelination. It 
was felt this it was unlikely the migration of endogenous Schwann 
cells could account for this extent of myelination in the presence of 
numerous identified transplant cells. The investigators of this study 
also thought exogenous contamination of the OEC suspension with 
Schwann cells from the transgenic donor animal was unlikely, given 
the high purity (> 95%) of their cultures.
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There are other observations that shed new light on the interactions 
between endogenous Schwann cells and grafted OECs. Mucosal 
OECs labelled with green fluorescent protein (Ramer et al., 2004) 
transplanted into acute mouse and rat spinal cord lesions survived 
for less than 60 days and simultaneously promoted the migration of 
host Schwann cells into the lesion site. Although, migration of host 
Schwann cells has previously been observed in the lesioned spinal 
cord (Li et al., 1999), it has generally been difficult to distinguish 
grafted OECs from host Schwann cells due to their great similarity in 
appearance (they look alike and both stain for the same markers). It 
is therefore quite possible that some of the effects attributed to OECs 
might have been mediated by endogenous Schwann cells. On the 
other hand, it cannot be ruled out that there may be important 
differences between mucosal and bulbar OECs and studies with 
GFP-labelled bulbar OECs would have been useful. Unfortunately, 
the vector carrying GFP used in out laboratory turned out to be 
neurotoxic. The aforementioned study by Ramer highlighted two 
other interesting aspects. Firstly, OECs reorganised astrocytic 
processes and chondroitin sulphate proteoglycan (CSPG) deposition 
into longitudinal and radial streams which were re-aligned with 
astrocytic processes, akin to the arrangement seen in my own 
studies (Fig 10), whereas astrocytes formed a dense barrier in the 
control group. Secondly, these studies also reported a differential 
axonal response to mucosal OECs. The mucosal OECs recruited
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only serotonin- and 5 hydroxytrytophan (5HT)-positive axons but did 
not facilitate the ingrowth of rubrospinal axons.
Neural crest stem cells
NCSCs demonstrated their ability to adopt either a neural or a glial 
fate. Those cells that had adopted a glial fate expressed nestin and 
p75 just like OECs and Schwann cells did. This is not surprising, 
after all, Schwann cells are derived from the neural crest. Some of 
the cells became NF- and peripherin-positive neurones. These 
newly formed neurones were mainly situated in the bolus part at the 
ventral end of the graft. There was a clear segregation into glial and 
neuronal populations. The glial cells were mostly seen in the column 
whereas neurones were encountered in the bolus at the ventral end 
of the graft. This would indicate that the cells are responding to 
specific local cues (Stemple and Anderson, 1993) (Mori et al., 1990) 
that determine their differentiation fate. This mechanism is well- 
known from the development of the neural crest and has also been 
observed in culture.
The grafts recruited axons which were distinctively different from 
axons normally observed in OEC and Schwann cell grafts. They 
were very fine and delicate. Their precise origin could not be 
established but it appears unlikely that the newly formed neurones 
gave rise to them. These neurones gave only rise to thicker and 
much shorter NF- and peripherin-positive axons than those seen in
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the column part of the graft. Equally, it cannot be ruled out that 
peripherin might lack the sensitivity of NF in staining fine axons and 
hence the jury is still out on whether or not those axons observed are 
of host or donor origin. Another interesting observation was the fact 
that the newly formed neurones did not express any nestin. In 
culture all NCSCs express nestin, a marker of immature 
neuroepithelial tissue. Newly formed Schwann cells, on the other 
hand, retain their capacity to express nestin just like normal Schwann 
cells and OECs do.
Culturing of NCSCs proved to be extraordinarily difficult due to the 
high sensitivity of these cells and several cultures failed. For this 
reason only a small number of samples from only one animal could 
be investigated.
Human olfactory ensheathing cells
The main purpose of this investigation lay in demonstrating that 
human and rat OECs are similar cell types in terms of their 
regenerative potential and hence human OECs could reasonably be 
expected to work in human CNS injuries. My experiments have 
clearly shown that human OECs can survive in the thalamus and 
attract axons. The recruitment process of axons, however, is 
impeded by the host immune response. Anti-human mitochondria 
(MIT)-staining in rats that had received only oral cyclosporine 
revealed a honeycomb-like morphology and areas of cell necrosis
172
interspersed with surviving areas. Very few axons were ever seen in 
these samples. Blood vessels adjacent to the graft displayed the 
tale-tell sign of perivascular cuffing and there was also an intense 
infiltration of the graft by T-lymphocytes. Oral administration of 
cyclosporine may not lead to sufficient levels of the drug at the site of 
the graft(Mehl et al., 2003) (Noble and Markham, 1995). Erratic 
absorption from the gut is a common problem in many drugs and 
cyclosporine is no exception to this rule. Furthermore, the 
cyclosporine preparation administered in the rat’s drinking water is 
only meant to be used for systemic intravenous infusion in humans.
Systemic immunosuppression with cyclosporine failed to abolish 
rejection completely but improved cell survival and axon recruitment. 
Perivascular cuffing was not seen and although T-cell infiltration was 
evident by 7 days it was only weakly detectable by 14 days. MHC II- 
complex expression was fairly pronounced and indicated that 
rejection still occurred. MHC-I complex was only mildly and diffusely 
expressed by the graft. Many of the cells expressing MHC II- 
complex had a microglia-like appearance and lay in the brain 
parenchyma at the border to the graft. This finding would imply that 
antigen presentation by microglia is an important mechanism of 
rejection, even in the presence of systemic immunosuppression with 
cyclosporine. Observations in rats and mice receiving embryonic 
ventral mesencephalic tissue from the pig have identified CD8-
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positive cells and microglia (Larsson et al., 2001) as the main effector 
cells in the late, cyclosporin A-resistant rejection stage.
The axon measurements show that it is mainly axon elongation 
rather than the actual number of axons that is affected by the 
immune response. In keeping with falling levels of infiltrating T- 
lymphocytes the number of axons increased by 14 days. The 
measured length of axons was very short and comparable to the 
sham group. Clearly, the conditions for axon growth were suboptimal 
in these xenografts. One might speculate that neurotrophic factors 
attracted axons in the graft but that local inhibitory factors like 
complement, antibodies and reactive oxygen species from immune 
cells and macrophages stunted the growth of axons. Another more 
likely possibility would be that the immune response interfered with 
normal donor cell function, hence leading to attenuated levels of 
neurotrophic support.
Unfortunately, attempts at using liposomal tacrolimus failed. Perhaps 
tacrolimus had a neurotoxic effect on the cell suspensions. 
Tacrolimus is known to be neurotoxic and liposomes can be difficult 
to prepare (Alemdar,A.Y, personal communication). Thus, 
differences in preparation may play a possible role.
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The fornix as a model
Failure of axon regeneration
Partial lesions were discarded from further examination. It was often 
difficult to tell whether a lesion was entirely complete and this 
required the careful study of stained adjacent sections. Samples 
where intact fornix fibres were seen at the periphery of the lesion or 
without an apparent lesion were considered as incomplete. Surviving 
fibres were seen in samples with lesions off the centre of the tract or 
where the lesion had become smaller than the width of the fornix.
It is hard to tell why the experiments on the fornix did not lead to any 
axon regeneration. None of the cells tested (OECs, NSCs and 
embryonic brain cells (E14) cells) had any impact on regeneration. 
Previous experiments (Stichel et al., 1996) on the postcommissural 
fornix apparently demonstrated a high ability of this fibre tract to 
regenerate in the presence of Schwann cells. Those lesions were 
made by simply severing the tract with a wire knife and only caused 
minimal mechanical damage. Stichel’s work has a number of 
methodological shortcomings. The fornix is a very flexible structure 
and lowering a knife down to sever it may lead to some displacement 
of the fornix. Hence, the lesion may not be complete and what 
appears to be a regenerated tract might actually be nothing more 
than surviving axons. The lesions were also not reconstructed in 3
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dimensions to prove their completeness. The results have yet to be 
reproduced by other groups.
Radiofrequency heat lesions under conditions of high electrical 
resistance due to the deep position of the electrode can be expected 
to cause fairly extensive tissue damage. The histological sections of 
pure lesions clearly show that this is indeed the case. Most lesions, 
including those with cell transplants, harbour a necrotic core in the 
centre. Cells and astrocytic processes are organised in a concentric 
fashion around the central necrosis. It may be that candidate repair 
cells are encountering such adverse conditions that regeneration is 
simply not possible.
Stichel’s group believes that there is only a very short time-window of 
less than 24 hours (Stichel et al., 1999a) for axon regeneration when 
NSCs are used to repair the severed postcommissural fornix. 
However, it is not clear whether this is related to intrinsic properties 
of the NSCs. Experiments have yet to establish the capacity of 
OECs in immediate and delayed transplantation of the severed fornix 
and compare them to Schwann cells. Interestingly, axons derived 
from other parts of the CNS were observed in the delayed grafts 
which were not of subicular origin. The same authors had claimed in 
previous studies (Stichel et al., 1999b) that reduction of the basal 
membrane formation allowed fornix regeneration up to 3 days after 
the original injury.
176
It is therefore at present unclear whether it is the damage caused by 
the lesion itself or certain intrinsic properties of the fornix that are 
responsible for regenerative failure. Although the former possibility is 
partly supported by the extensive tissue damage seen at the lesion 
site, the detection of axons in the lesion raises questions regarding 
intrinsic properties of various fibre tracts.
Another reason for investigating E14 cells was to find out if immature 
cells with a high developmental potential would confer any advantage 
over normal more mature glial cells. The experiments clearly show 
that this is not the case. Axons failed to penetrate the graft. The 
graft had a heterogenous appearance and lacked specific expression 
of markers like p75, GFAP and NF. Nestin expression was not 
investigated. Interestingly, diffuse p75 expression was only seen 
where the graft was in close proximity to the fornix. Hence, some of 
the E14 cells were able to differentiate into glial cells provided they 
had contact with the fornix. This is in keeping with the ability of 
immature and stem cells to differentiate according to local cues . 
The lack of specific markers for the remaining cells indicates that 
they retained a high degree of immaturity.
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Improved experimental design for future studies
Donor cell purification
Future studies will ensure that defined protocols are strictly followed 
for each donor cell type, using comparable passage stages and with 
careful monitoring of culture quality. This should reduce the amount 
of variability between cultures and ultimately improve the consistency 
of the cell transplantation experiments.
The donor cells to be studied include Schwann cells derived from 
adult (ASCs) and neonatal (NSCs) rats and olfactory ensheathing 
cells (OECs) derived from both the rat and human olfactory bulb and 
the olfactory mucosa. It may be worthwhile comparing neonatal and 
adult olfactory ensheathing cells from the bulb and comparing cells 
from cultures at different passage stages.
Schwann cells derived from neonatal tissue
Schwann cells will be derived from neonatal rat pups (postnatal day 
1-2) using cytosine arabinoside to reduce the number of rapidly 
dividing cells, followed by a complement kill using guinea pig or 
rabbit complement and Thy 1 IgM antibody (Brockes et al., 
1979;Raisman et al., 1993;Lakatos et al., 2000). These purification 
steps result in a concentration of approximately 95-98% neonatal 
Schwann cells. A further purification can be achieved because of the
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differential adhesion properties of fibroblasts and Schwann cells 
(Wrathall et al., 1984).
Schwann cells derived from adult tissue
The explant technique previously described by Morrissey et al., 1991 
to obtain Schwann cells from adult sciatic nerves yielded Schwann 
cells of up to 98 % purity when combined with glial derived growth 
factor and forskolin to expand Schwann cell numbers. In practice, 
without the use of these chemicals the usual purity obtained was 
closer to 80 -  90 % (Brook et al., 1994). However, purification of the 
cell suspension can be further improved using differential adhesion 
(Wrathall et al., 1984). The complement kill method does not work 
well on more mature fibroblasts. The distinct morphology of Schwann 
cells (spindle-shaped) and fibroblasts (large, flattened) in vitro 
permits assessment of culture purity using phase contrast 
microscopy. Using this method it will be possible to assess donor cell 
purity prior to transplantation.
In order to determine the effect of contaminating fibroblasts, defined 
mixtures of purified cells may also be transplanted since there is 
evidence to show that mixed cultures compared to purified cultures 
have no apparent negative effect on axon regeneration (Keyvan- 
Fouladi et al., 2005) and also anecdotal evidence that mixed cultures 
may have superior regeneration potential (Prof G. Raisman, personal 
communication). Therefore, prior to transplantation purified cultures
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of Schwann cells could be mixed in defined concentration (5 % and 
10 %) with fibroblasts left over from the Schwann cell preparation.
Olfactory ensheathing cells
Adult olfactory ensheathing cells (OECs), of both human and rat 
origin from either the olfactory bulb or the olfactory mucosa, will be 
cultured as previously described (see page 50 and 52) and further 
purified either 1) by fluorescence-activated cell sorting exploiting the 
fact that these cells express 04 but not Gal-C (Barnett et al., 1993) 
or 2) by magnetic beads loaded with anti-p75 antibody. Since OECs 
express the p75 low affinity nerve growth factor receptor they bind to 
the beads and the beads can be collected by a magnet (Barnett et 
al., 2000).
Donor cell purity could be assayed by immunofluorescence using 
p75 antibody to detect OECs and Schwann cells and fibronectin to 
detect fibroblasts in the sample.
Labelling of donor cells
It is important to clearly identify transplanted donor cells to exclude 
the possibility of endogenous cells from the meninges, the 
subventricular zone or the olfactory bulb migrating to the site of the 
graft. Labelling the donor cells would permit their unambiguous 
identification. There are a number of methods available.
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i) Cultured cells can be labelled with bromodeoyxuridine (BrdU), a 
synthetic nucleoside that is incorporated in place of thymidine in the 
replicating DNA of dividing cells. BrdU can be identified with 
antibodies following denaturation of the DNA by incubation in an acid 
or a base or by simple heat treatment. The intensity of the signal 
depends on the number of cell divisions after incubation since each 
division dilutes the concentration of BrdU. Cell cultures can be 
incubated overnight with 10 pi BrdU added to each ml of tissue 
culture solution at a concentration of 1 mM working solution of BrdU 
(BD Biosciences Pharmingen). After a further 24 -48 hours in normal 
culture medium the cells are ready to be transplanted. After 
transplantation the cells can be detected by a specific antibody 
against BrdU (Pollock et al., 1999).
ii) Another method of cell identification involves the transplantation of 
male donor cells into female recipients. The Y-chromosome in the 
cell nucleus is detected by fluorescence in-situ hybridization (FISH). 
It is possible to unequivocally identify donor cells using 
immunofluorescence for a specific antibody combined with FISH for 
the Y chromosome (Trotman et al., 2004).
iii) LacZ is the gene coding for R-galactosidase, an enzyme found in 
E. coli bacteria but not expressed by eukaryotic cells. Hence it can 
be used as a reporter and marker gene. Potential donor cells can be 
infected by a replication-deficient retrovirus carrying the LacZ gene in 
vitro and LacZ expression by grafted cells can be identified with a 
specific antibody against fl-galactosidase (Boyd et al., 2004).
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iv) Green fluorescent protein (GFP) derived from the jellyfish 
Aequorea victoria is widely used as a method for identifying donor 
cells. Donor cells can be derived from commercially available 
transgenic animals expressing GFP. Alternatively donor cells can be 
transfected with GFP in culture. Transfection is usually achieved by 
using appropriate vectors. Lentiviruses are particularly suitable as 
they are capable of infecting both dividing and non-dividing cells. A 
direct transfer of DNA through electrical or chemical permeabilization 
of the target cell membrane is also possible but less effective. 
Olfactory ensheathing cells have previously been successfully 
transfected by means of the stable viral producer line PA317 with the 
retroviral vector plasmid DNA pLXSN-GFP using the ecotropic 
packaging cell line psi-2 (Tuszynski et al., 1996). The donor cells in 
culture at an early passage stage are then infected with replication- 
deficient virus collected from the packaging cell line’s medium. GFP- 
expressing donor cells can then be enriched by a fluorescent- 
activated cell sorting procedure.
Labelling with GFP has a number of advantages, since the cells can 
be identified directly under the confocal microscope, without the need 
for antibodies and the whole cell is displaying green fluorescence 
(unlike the techniques which label the nucleus alone).
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Transplantation sites and improved lesioning 
techniques
The thalamus (see page 36) remains the transplantation area of 
choice. The model is well-established and no specific modification to 
the method of injecting cell suspensions into the thalamus is 
required.
The fornix (see page 47) was selected as another transplant site 
since it had the potential to show axon re-entry into the host and 
reconnection of axons to the target area. Unfortunately, the 
radiothermic lesions were probably too destructive to allow 
regeneration of the post-commissural formix tract (see page 176). In 
the original experiment axon fibres were severed with a wire-knife 
(Stichel et al., 1996). The potential risk with this approach is that fibre 
tracts may be displaced rather then severed. I would like to use this 
lesioning technique with transplantation but combine it with a three- 
dimensional reconstruction in order to distinguish regenerating axons 
from surviving or displaced host axon fibres. Three-dimensional 
reconstruction of fibres labelled with biotin dextran (BD) or other 
tracers (since BD has been reported to cause unreliable labeling, 
(Tsai et al., 2001)would distinguish remaining undamaged axons 
from regenerating axons which could be identified with antibodies to 
neurofilament protein or GAP 43. The 3D reconstructions could be 
made using confocal microscopy of thick sections of the tissue 
sample. Confocal microscopy allows each thick section to be
scanned in micron intervals. However, it would be necessary to scan 
several adjacent sections to build up a 3D image. Alternatively 
sections may be assessed using a conventional microscope with an 
image analysis package.
It might be worthwhile to label the subiculum with an anterograde 
tracer and the mammillary body with a retrograde label (although the 
latter method is technically very challenging) to assay the degree of 
regeneration through the fornix after lesioning and transplantation.
Control of host immune response
The transplantation of human cells into a rat host poses a particular 
challenge since xenografts are forcefully rejected by the host 
immune system. It is only possible to reliably assess the intrinsic 
survival capacity and the ability of grafted human OECs to influence 
axon recruitment under conditions that are not adversely affected by 
the influx of immune cells directed against the human xenografts. 
Various methods exist to suppress the host immune response. 
Cyclosporine or tacrolimus only suppress T-cell mediated immunity 
but do not protect from preformed antibodies acting via complement 
lysis or via antibody-dependent cellular cytotoxicity. Another draw­
back of these drugs is their high nephrotoxicity leaving only a small 
therapeutic time window. Various other strategies can be employed 
to improve survival in neural xenotransplantation. These range from 
the administration of anti-CD4 monoclonal antibody (Wood et al.,
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1996) or blocking of the IL-2 receptor (Honey CR et al., 1990) to 
more complex multi-antibody therapies (Larsson et al., 2003) aimed 
at blocking multiple activation receptors of the immune response. 
Much interest has also focused on finding ways of protecting the 
grafted cells from the effects of apoptosis (Hansson et al., 2000). 
More recent experiments have also raised the possibility of inducing 
immune tolerance (Fandrich et al., 2002) by grafting embryonic stem 
cells prior to grafting of a specific organ. The holy grail of transplant 
medicine is to achieve true immunotolerance to a given antigen but 
this technology is in its infancy and therefore not a practical 
alternative.
However, proof of principle can be achieved using athymic rats which 
are commercially available. They must be reared under germ-free 
and specific pathogen-free conditions and care must be taken during 
surgery to reduce the risk of infection. They are incapable of 
producing sufficient numbers of T-cells and hence mounting a T-cell 
mediated immune response since T-cell development and maturation 
depend on the thymus (Pearse, 2006). Only a few T-lymphocyte 
marker-positive cells are found in the athymic nude rat but they do 
have normal levels of B-lymphocytes (Hougen, 1991). However, 
they have been successfully employed as recipients of canine OECs 
(Smith et al., 2002) and also of human OECs when transplanted into 




Sections will be fixed in either acetic alcohol or 4 % 
paraformaldehyde depending on the sensitivity of the antibodies 
used. Slides will then be washed in PBS followed by quenching of 
endogenous peroxidase activity by incubation in 0.3 % of H2O2 in 
water, further rinsing and then be blocked in 5 % defatted milk in 
PBS followed by incubation overnight at 4°C with the primary 
antibody. Triton or Tween may be used to improve antibody 
penetration. Primary antibodies will be diluted in a solution of 0.05 % 
azide (NaN3) and 1 % BSA in PBS. After another wash cycle a 
secondary biotinylated antibody directed against the primary antibody 
will be used. The final steps involve the incubation with avidin-biotin 
complex conjugated with horseradish peroxidase (Vectastain ABC 
Kit, Vector Laboratories Ltd.) and processing as previously described 
(see page 73).
In any staining protocol some sections will be left in blocking solution 
without primary antibodies as negative controls. Any staining 
observed after application of the secondary antibody would hence be 
non-specific and indicate cross-reactivity with the sample tissue itself. 




Sections will be fixed in either acetic alcohol or 4 % 
paraformaldehyde depending on the antibodies used. Alternatively 
animals may be perfusion-fixed with paraformaldehyde. This is 
essential for animals where donor cells have been labelled with GFP 
since my previous studies have shown a tendency for GFP to leak 
out from the cells if they are not fixed immediately after the death of 
the animal.
Sections will then be washed and incubated overnight in the primary 
antibodies (mouse and rabbit in conjunction) diluted in 1 % bovine 
serum albumin and 0.05 % azide in PBS plus 0.2% Triton). After 
washing, sections will be incubated in two different fluorochrome- 
conjugated secondary antibodies which recognise the animal in 
which the primary antibodies were raised.
For the negative controls the primary or secondary antibodies may 
be omitted. This will permit the identification of autofluorescent 
macrophages.
Antibodies
The standard panel of antibodies will be used as described before 
(see page 71) supplemented by a number of specific antibodies, 
outlined below. OECs and Schwann cells display a similar 
immunostaining pattern for nestin and p75. Co-localisation studies 
will be required to verify these observations. Nestin gives a clearer
187
and more reliable staining pattern than p75 and would be the ideal 
replacement for p75 in many instances.
Markers of immunorejection or inflammation: A number of antibodies 
are available to detect lymphocytes, the MHC complexes and 
macrophages and microglia. OX-18 recognises rat MHC class I 
antigen and OX-6 recognises MHC class II antigen. Anti-rat CD4 
(W3/25) recognises the CD4 receptor expressed by helper T-cells 
and to a lesser degree by microglia and macrophages and anti-rat 
CD8 (OX-8) recognises mainly the CD8 receptor expressed by 
suppressor T-cells. Microglia and macrophages can be detected by 
0X42 and CD68. Other markers that might be useful are the pan B- 
cell marker CD19 and the pan-leukocyte antibody CD18). The 
different cell types assayed may provoke differing degrees of 
microglial response or immune response which will be of importance 
for translational studies.
Detection of regenerating axons: GAP 43 (growth-associated protein 
43 with a molecular weight of 43 and above) is expressed by both 
developing and regenerating axons. Other markers associated with 
regeneration or response to injury of axons are CAP-23, SCG10, c- 
jun, L1 and CHL1 (Chaisuksunt et al., 2000). These proteins are 
upregulated when peripheral nerves are grafted into the cerebellum. 
Rabbit polyclonal antibodies to GAP43 and c-jun are commercially 
available. These two proteins have been shown to correlate with
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those axons from the thalamus, in particular those arising from the 
thalamic reticular nucleus that are attracted into peripheral nerve 
grafts (Vaudano et al., 1998b). Therefore, both the axons seen in the 
thalamus model and the ones seen in the fornix model should be 
examined for the presence of these two markers.
Markers of scar formation and non-specific inflammation: Injury to the 
CNS in its mildest form (eg. insertion of micropipette) only leads to 
very mild non-specific inflammation (Davies SJ et al., 1996). Where 
injury is more extensive there is an intense reactive gliosis (Silver 
and Miller, 2004) resulting in the formation of a ‘glial scar’. This scar 
is heterogeneous in its composition and consists of reactive 
astrocytes, macrophages, fibroblasts, oligodendrocytes, endothelial 
cells, leukocytes and various non-cellular extracellular matrix 
components such as proteoglycans (Asher et al., 2001). Chondroitin 
sulfate proteoglycan (CSPG) is one of the components of the 
extracellular matrix that contributes to the inhibition of axon 
regeneration. It can be identified using various antibodies directed 
against different epitopes of CSPG (Yick et al., 2003). Reactive 
astrocytes can be detected by the presence of GFAP as previously 
described and macrophages/ microglia and oligodendrocytes (also 
inhibitory to axon regrowth) can be detected by antibodies raised 
against 0X42 and myelin basic protein respectively.
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An absolute pre-requisite for successful graft taking is the rapid 
formation of a good blood supply. More samples should therefore be 
investigated for the expression of von Willebrand factor (vWF), a 
marker expressed by endothelial cells. My preliminary findings seem 
to suggest that the amount of p75-immunoreactivity corresponds 
roughly to the extent of vascularisation or in other words that 
surviving p75 positive donor cells are positively correlated to the 
ingrowth of blood vessels. This relationship is by no means certain 
and a sufficient number of samples would be required to support it. 
Antibodies directed against vWF can be used to elucidate the 
vascular response to injury (intense scar formation will lead to the 
formation of new blood vessels) but is also useful to show the 
desired neovascularisation of the graft itself.
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Data collection and analysis
Slides should be analysed blind. This can be achieved by a co­
worker assigning random codes to the slides prior to axon counting 
by another co-worker (who is unaware of the various treatments). 
Axons should be counted on several slides per individual sample and 
the two-dimensional count should be compared with the three- 
dimensional reconstruction count. With the appropriate software it 
should also be possible to obtain automatic counts which would not 
be affected by human bias.
It will be useful to have equal numbers of animals for each donor cell 
type and each survival time. This will make the statistical analysis 
easier and a parametric test like ANOVA (analysis of variance, a test 
that depends on normally distributed data and equal group sizes) can 
then be employed. The sample size needs to be large enough to 
estimate whether the sample distribution corresponds to the 
expected Gaussian distribution. If these criteria are not fulfilled a 
rank-transformed test like the Kruskal-Wallis one-way analysis of 
variance can be used.
Application of these improvements should yield more clearly 
interpretable data in relation to axon regrowth and host tissue 
responses which, in turn, may contribute to the use of these cells in 
translational studies for the clinic.
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Conclusions
My experiments have shown that the thalamus is a suitable assay 
system for assessing cell survival, host/graft interactions and axon 
recruitment. Cell suspensions can be grafted in to the thalamus in a 
short space of time and the appearance of the grafts is relatively 
consistent. The experiments have shown that all candidate repair 
cells in the absence of a strong immune attack can survive in the 
thalamus. All the candidate repair cells were able to recruit axons. 
There appeared to be a relationship between the degree of cell 
organisation and the mean length and density of axons attracted into 
the graft. The more immature neonatal Schwann cells (NSCs) fared 
best in this respect, closely followed by olfactory ensheathing cells 
(OECs) from the mucosa. Both cell types were highly organised with 
long and slender nuclei nicely arranged in parallel tiers. OECs from 
the bulb had large and plump nuclei and appeared overall more 
scattered. They were associated with fibres of shorter mean length 
and density. It was unexpected that OECs from different locations 
would behave so differently. It seems that cell cultures from these 
two primary tissues are actually quite different. OECs from the 
mucosa might consist of more immature cells, possibly closer to the 
NSC. The fact that the olfactory mucosa harbours putative stem 
cells which may give rise to OECs would lend support to this theory.
Neural crest stem cells (NCSSs) transplanted into the thalamus 
differentiated into separated populations of glial and neural cells
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corresponding to their behaviour in vitro and in development. The 
axons recruited into the NCSS columns were thinner than axons 
observed in the other cell grafts. This may represent the fact that this 
is a different class of axons from those recruited into the other cell 
columns, or the thinner diameter reflects an axonal response to 
differing local conditions in the graft.
The thalamus is particularly useful in performing studies where graft 
rejection poses a problem. Survival of human OECs from the 
mucosa was impaired by a vigorous immune response in rats that 
had only received oral cyclosporine but was better controlled by 
systemic administration of cyclosporine. Nevertheless, the immune 
response was not completely abolished by systemic administration of 
cyclosporine. Migratory behaviour of cells was not observed in 
human OECs. Axon recruitment was poor and practically 
indistinguishable from the sham group, although the mean axon 
density was higher after 14 days than in the sham group. The 
immune response impairs the growth of fibres in the graft. 
Nevertheless, these studies raise hopes that human OECs share 
common properties with rat OECs from the mucosa and could be 
useful for clinical applications in axon regeneration. Treating both 
the animal and the cells suspension with cyclosporine might improve 
survival and it would be worth repeating the experiments under those 
conditions and perhaps in immuno-incompetent nude rats as 
recipients.
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The fornix was chosen for its accessibility and structural simplicity, 
representing predominantly a unilateral projection from the subiculum 
to the mammillary body. It was hoped that this model would allow 
evaluation of the impact of the candidate repair cells on axon re-entry 
into the host. The fornix tract was severed not with a knife but 
through the creation of a radiofrequency heat lesion. This was 
followed by grafting of cells and labelling of the tract. Unfortunately, 
none of the NSC and OEC grafts led to axon recruitment into the 
graft even if NSCs were transplanted after a 14 day delay. 
Surprisingly, the cell grafts recruited axons of unknown origin from 
outside the fornix. Grafted cells did respond to the fornix and 
migrated away from the bolus into the remaining fibre tract, both 
proximal and distal to the lesion.
Foetal brain cells survived in the lesions but likewise had no 
influence on fornix regeneration. They did not display any of the 
typical glial or neuronal markers except when they came in direct 
contact with the uninjured fornix and expressed p75.
The failure of fornix fibres to regenerate into the graft could either be 
related to the extensive tissue damage associated with the 
radiofrequency lesions or might reflect certain intrinsic properties of 
the fornix. It remains to be seen whether the fornix is a suitable 
assay system from which one can draw conclusions relevant to other 
parts of the CNS, like the spinal cord. Future studies need to 
address this and focus on scar tissue formation at the lesion site as
194
well as compare OEGs and NSCs in animals having the fornix tract 
severed by mechanical means only.
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